TWI241347B - A process for producing an aglucone isoflavone enriched vegetable protein whey from a vegetable protein whey and materials produced therefrom - Google Patents

A process for producing an aglucone isoflavone enriched vegetable protein whey from a vegetable protein whey and materials produced therefrom Download PDF

Info

Publication number
TWI241347B
TWI241347B TW86115277A TW86115277A TWI241347B TW I241347 B TWI241347 B TW I241347B TW 86115277 A TW86115277 A TW 86115277A TW 86115277 A TW86115277 A TW 86115277A TW I241347 B TWI241347 B TW I241347B
Authority
TW
Taiwan
Prior art keywords
isoflavone
scope
patent application
item
substance
Prior art date
Application number
TW86115277A
Other languages
Chinese (zh)
Inventor
Jerome Shen
Mark A Roussey
Barbara A Bryan
Maryann C Allred
Original Assignee
Protein Tech Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/627,301 external-priority patent/US5851792A/en
Application filed by Protein Tech Int filed Critical Protein Tech Int
Application granted granted Critical
Publication of TWI241347B publication Critical patent/TWI241347B/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)

Abstract

An aglucone isoflavone enriched vegetable protein whey, whey protein material, high genistein material, high daidzein material, and aglucone isoflavone material are provided, as well as a process for producing the same from a vegetable protein whey. Isoflavone conjugates in a vegetable protein whey are converted to isoflavone glucosides by treating the whey at a temperature and a pH for a period of time sufficient to effect the conversion. The isoflavone glucosides are converted to aglucone isoflavones by enzymatic reaction to produce an aglucone isoflavone enriched vegetable protein whey. Aglucone isoflavone whey protein material is recovered from the aglucone isoflavone enriched vegetable protein whey. A high genistein content material, a high daidzein content material, and an aglucone isoflavone material are produced from an alcohol extract of the aglucone isoflavone whey protein material.

Description

1241347 A7 B7 五 '發明説明( 經濟部中央標準局員工消費合作社印製 發明背景 本發明係有關富含配基異黃酮之植物性蛋白質乳漿、富 含配基異黃酮之乳漿蛋白質物質、配基異黃酮物質、高 5,7,4 -二羥基異黃酮含量物質和高'-二羥基異黃酮含 量物質及自植物性蛋白質乳漿製造彼等之方法。 廿異更酮出現在多種豆類植物,包括植物性蛋白質物質如 更U。此些化合物包括7,4、二羥基異黃酮糖苷、6" _ =Ac 7,4'_二羥基異黃酮糖甞、6、〇]y[al 74,_二羥基異 二酮糖#、7,4'_二羥基異黃酮、5 7 4、三羥基異黃酮糖 甞、6"_〇Ac 5,7,4、三羥基異黃酮糖甞、6,,_〇Mai 1,7,4'_三羥基異黃酮糖芬、5,7,4,_三羥基異黃酮、6_ 氧基_7,4 _ 一羥基異黃酮糖菩、6"_〇Ac “甲氧基_ 二羥基異黃酮糖甞、6,,_〇Mal L甲氧基_74,_二羥基昱 黃酮糖甞、6-甲氧基_7,4,_二羥基異黃酮、4,·甲氧基、_ 二羥基異黃酮、4、甲氧基_57_二羥基異黃酮 甲氧基基異黃酮和香豆雌醇(⑶⑽灿叫。 在商業產ρα <製造中,如植物性蛋白質分離物和濃 :傳ί點Ϊ:去此些物質。例如,在製備黃豆蛋白分離物 (傳、-无万法中’其中黃豆片以水性驗媒液萃取, 2黃ί蛋白一起溶於萃取液中。蛋白質自萃取液由酸化 单取欣沈澱及經分開以形成分離物,留下保有許多溶化里 頁酮(乳漿。在酸沈澱蛋白質分離物中留下之殘切里、 物之徹底清洗除去。乳浆和清洗液典型:丟 棄。在植物性蛋白質乳衆中之異黃嗣包括異黃_細 甲 4,· 縮 ί§. «ϋ«ι ϋϋ 4—l.t 1·.—.—· —Β^ν —B^^i ·1 (請先閱讀背面之注意事項再填寫本頁} μ氏張尺度適用中國 -4- 經濟部中央標準局員工消費合作社印製 1241347 A7 五、發明説明(2 苷體)、異黃體共軛物和配基異黃酮。異黃酮糖苷具連接 至化合物之異黃酮部分之葡萄糖分子。異黃酮共概物具連 接至葡萄糖分子之附加部分,例如6"-〇Ac 5,7 4,_三_ 基異黃酮具連接至葡萄糖分子之6位置之乙酸根基團。配 基異黃酮包括異黃酮部分,而無連接之葡萄糖分子。 黃豆乳漿含三“族,,異黃酮化合物,具相對應之糖甞、 共軛物和配基成員:5,7,4、三羥基異黃酮族、74、二羥 基異黃酮族和6 -甲氧基-7,4、二羥基異黃酮族。5 7 4,_ 三羥基異黃酮族包括糖甞5,7,4'_三羥基異黃酮糖萁’、共 軛物6〃-0Mal 5,7,4'_三羥基異黃酮糖甞(574,_三羥基 異黃酮糖甞之6"-丙二酸酯)和6、0Ae 5 7,4、三羥^ 黃酮糖甞(5,7,V-三羥基異黃酮糖甞之6"_乙酸酯)和配基 5.7.4、 三羥基異黃酮。7,4、二羥基異黃酮族包括糖荅 7,4'_ 一經基異衷酮糖嘗、共輛物6〃-〇Mal 7,4,_二經基 異黃酮糖甞和6"-0Ac 7,4'-二羥基異黃酮糖甞及配基 7.4、 二經基異黃酮。6-甲氧基_7,4、二羥基異黃酮族包 括糖苷6 -甲氧基-7,4、二羥基異黃酮糖甞、共軛物 OMal 6 -甲氧基-7,4f -二羥基異黃酮糖:y:和配基6_甲氧基 _7,4f-二羥基異黃酮。 雖然所有異黃酮係重要於醫學評估,但是配基爲最重要 之特定異黃酿I。5,7,4'-三經基異黃酮和7,4,-二邊基異黃 酮可顯著降低心血管危險因子。“植物和哺乳類雌激素在 母猴之血脂上之影響’檐橡’ 90卷,1259頁(1994年 10月)。5,7,4’-三羥基異黃酮和7,4、二羥基異黃酮亦被 -5- 本紙張尺度適用中國國家標準(CNS ) A4規格(210x297公釐)1241347 A7 B7 Five 'invention description (printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economics Background of the Invention The present invention relates to a vegetable protein milk rich in aglycone isoflavones, a milk protein protein rich in aglycone isoflavones, Base isoflavone substance, high 5,7,4-dihydroxy isoflavone content substance and high '-dihydroxy isoflavone content substance, and a method for producing them from plant protein milk. , Including plant-based protein substances such as U. These compounds include 7,4, dihydroxy isoflavone glycosides, 6 " _ = Ac 7,4'_ dihydroxy isoflavone glycosides, 6, 0] y [al 74, _Dihydroxyisodione sugar #, 7,4'_dihydroxy isoflavones, 5 7 4, trihydroxy isoflavone glycosides, 6 " _Ac 5,7,4, trihydroxy isoflavone glycosides, 6, , _〇Mai 1,7,4'_trihydroxy isoflavone glycofen, 5,7,4, _trihydroxy isoflavone, 6_oxy_7,4 _ monohydroxy isoflavone sugar, 6 " _〇Ac "Methoxy_dihydroxy isoflavone saccharin, 6 ,, 〇〇Mal L methoxy_74, _dihydroxy flavonoid saccharin, 6-methoxy_7,4, _dihydroxy isoflavone, 4 , · Methoxy _ Dihydroxy isoflavones, 4, methoxy_57_ dihydroxy isoflavones methoxy isoflavones, and coumestrol (CD⑽can called. In commercial production ρα < manufacturing, such as plant protein isolates and concentrated : Chuan Lidian: remove these substances. For example, in the preparation of soy protein isolate (Chuan,-Wu Wanzhong 'where the soybeans are extracted with an aqueous vehicle solution, 2 yellow protein is dissolved in the extract together. Protein The self-extract is separated from the acidified single precipitate and separated to form an isolate, leaving a lot of solubilized liptonone (milk. The residue left in the acid-precipitated protein isolate is thoroughly washed and removed. Milk Pulp and cleaning solution are typical: discarded. Isoflavones in plant-based protein milk include isoflavone _ fine nail 4, reduced §. «Ϋ« ι ϋϋ 4—lt 1 · .—.— · —B ^ ν —B ^^ i · 1 (Please read the precautions on the back before filling in this page} μ scale is applicable to China-4- Printed by the Central Consumers Bureau of the Ministry of Economy Staff Consumer Cooperative 1241347 A7 V. Description of the invention (2 glycosides ), Isoflavone conjugates and aglycone isoflavones. Isoflavone glycosides are attached to the compound Isoflavone moiety of glucose molecule. Isoflavone co-prototypes have additional moiety attached to glucose molecule, such as 6 " -〇Ac 5,7 4, _tri-isoflavone with acetate group attached to the 6 position of glucose molecule Ligand isoflavones include isoflavone moieties without linked glucose molecules. Soymilk contains three "family," isoflavone compounds with corresponding glycans, conjugates and ligand members: 5,7,4 , Trihydroxy isoflavones, 74, dihydroxy isoflavones, and 6-methoxy-7,4, dihydroxy isoflavones. The 5 7 4, _ trihydroxy isoflavone family includes the glycocalyx 5,7,4'_trihydroxy isoflavone glycocalyx ', the conjugate 6〃-0Mal 5,7,4'_trihydroxy isoflavone glycocalyx (574 , _Trihydroxy isoflavone glycoside 6 " -malonate) and 6,0Ae 5 7,4, trihydroxy ^ flavonoid glycoside (5,7, V-trihydroxy isoflavone glycoside 6 " _B Acid ester) and ligand 5.7.4, trihydroxy isoflavones. 7,4, dihydroxy isoflavone family includes glycocalyx 7,4'_ diacyl isoflavone sugar taste, a total of 6 〃-〇Mal 7,4, _ diacyl isoflavone glycoside and 6 " -0Ac 7,4'-dihydroxy isoflavone glycocalyx and ligand 7.4, dimeryl isoflavone. 6-methoxy-7,4, dihydroxy isoflavone family includes glycoside 6-methoxy-7,4, dihydroxy isoflavone glycocalyx, conjugate OMal 6 -methoxy-7,4f -dihydroxy Isoflavones: y: and ligand 6_methoxy_7,4f-dihydroxy isoflavones. Although all isoflavones are important for medical evaluation, the ligand is the most important specific isoflavone I. 5,7,4'-trisyl isoflavones and 7,4, -dimeric isoflavones can significantly reduce cardiovascular risk factors. "Effects of plant and mammalian estrogen on blood lipids of female monkeys 'Eave Oak', Vol. 90, page 1259 (October 1994). Also -5- This paper size applies Chinese National Standard (CNS) A4 specification (210x297 mm)

1241347 Α7 Β7 發明説明( 3 認爲可降低在婦女中由降低或改變量之内源雌激素導致之 病症徵狀,如停經或行經前徵候群。再者,頃暸解在植物 性物質如黃豆中所含之配基異黃酮可抑制人癌細胞之生 長,如乳癌細胞和前列腺癌細胞,如述於以下文章:‘‘人 乳癌細胞生長之5,7,4 '-三羥基異黃酮抑制,獨立於雌激 素受體和多藥抗性基因”,由比特生和巴尼斯,生化學和 皇物理研究通訊,179卷,1期,661-667頁,1991年8 月30日;“日5,7,4'_三羥基異黃酮和4,-甲氧基-5,7-二 無基異黃酮抑制人前列腺癌細胞之生長,但無表皮生長因 子受體赂胺酸自磷酸化”,由比特生和巴尼斯,前列腺, 2 2卷,3 3 5 _ 3 4 5頁(1 9 9 3 );及“黃豆抑制在乳癌模式中之 乳房腫瘤”,由巴尼斯等人,在飲食之謗突變劑和謗癌 鼠,23 9-25 3 頁( 1 990)。 如上述,配基異黃酮包括7,4、二羥基異黃酮、5,7,4、 三羥基異黃酮和6-甲氧基-7,4、二羥基異黃酮。此些配基 具下式: 經濟部中央標準局員工消費合作社印裂1241347 Α7 Β7 Invention description (3) It is believed to reduce symptoms in women caused by a reduced or altered amount of endogenous estrogen, such as menopause or premenstrual syndromes. Furthermore, it is understood that in plant-based substances such as soybeans The contained isoflavones can inhibit the growth of human cancer cells, such as breast cancer cells and prostate cancer cells, as described in the following article: "Human breast cancer cell growth inhibition of 5, 7, 4'-trihydroxy isoflavones, independent For estrogen receptors and multidrug resistance genes ", by Bitson and Barnes, Newsletter of Biochemical and Imperial Physics Research, Volume 179, Issue 1, pages 661-667, August 30, 1991;" Day 5, "7,4'_trihydroxy isoflavones and 4, -methoxy-5,7-di-free isoflavones inhibit the growth of human prostate cancer cells, but there is no epidermal growth factor receptor glycine autophosphorylation." Pittson and Barnes, Prostate, Vol. 22, 3 3 5 _ 3 4 5 (19 9 3); and "Soybeans Inhibit Breast Tumors in Breast Cancer Model" by Barnes et al. Mutants and defamatory mice, 23 9-25 3 (1 990). As mentioned above, aglycone isoflavones include 7, 4, 2 Isoflavone, 5,7,4, genistein and 6-methoxy-7, 4, Dihydroxyisoflavone of such ligands having the formula: Ministry of Economic Affairs Bureau of Standards printed crack employees consumer cooperatives

其中Ri、R2、R3和R4可選自一群包括Η、〇H*〇CH3。 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐)Wherein Ri, R2, R3 and R4 can be selected from the group consisting of H, OH * OCH3. This paper size applies to China National Standard (CNS) A4 specification (210 × 297 mm)

1241347 A71241347 A7

五、發明説明(4 ) 5,7,4'-三羥基異黃酮具上式,其中Ri=〇h,R2 = h, R3 = OH及R4 = 〇H,7,4'_二羥基異黃酮具上式,其中 Ri = OH,R2 = H,R3 = H 及 R4 = 〇H,及 6-甲氧基 _7 4、二 羥基異黃酮具上式,其中ri = 〇h,r2 = 〇ch3,= R4 = 0H 0 因此,本發明係有關配基和植物性蛋白質乳漿之增濃及 具此些化合物之乳漿蛋白質物質,及特別地高5,7,4 三 瘦基異黃酮含量物質、高7, V -二羥基含量物質和配基異 黃酮物質。本發明亦有關於製造富含配基之植物性蛋白質 乳漿、富含配基之植物性乳漿蛋白質物質、高5,7,4 ^三 羥基異黃酮含量物質、高7,4、二羥基異黃酮物質和配基 異黃酮物質之方法。 經濟部中央標隼局員工消費合作社印製 轉換植物性蛋白質異黃酮共軛物成配基異黃酮之通常方 法係已知的,及提供於共同審理之美國專利申請案序號 08/477,102 ’ 1995年6月7日申請,由本説明書之讓受 人所有。轉換異黃酮糖苷成配基異黃酮之方法亦爲已知 的。在植物性蛋白質乳漿中轉換異黃酮糖甞成配基異黃酮 之方法係提供於共同審理之申請案PCT/US/94/10699, 由本説明書之讓受人所有。 其他轉換異黃酮糖苷成配基異黃酮之方法在技藝中亦爲 已知的,如述於日本專利申請案號2 5 8,6 6 9,予Ο b at a等 人。如此方法不提供異黃酮共軛物轉換成配基異黃酮或提 供高5,7,4'-三羥基異黃酮含量物質、高7,4f-二羥基異黃 酮含量物質或配基異黃酮物質。再者,此些僅達成轉化糖 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 口41347 A7 B7 克、發明説明(5 替成配基之中度程度,及需要實質之時段以完成此中度程 JKm g此’如此方法並不爲大量商業操作所需。 T此’本發明〈目標在提供富含配基異黃酮之植物性蛋 白質乳漿及自植物性蛋白質乳漿製備彼等之方法。 本發明之進一步目標在提供配基異黃酮乳漿蛋白質物質 及自植物性蛋白質乳漿製備彼等之方法。 本發明之再進一步目標在提供高5,7,4,_二羥基異黃酮 含量物質及自植物性蛋白質乳漿製備彼等之方法。 本發明之再進一步目標在提供高7,4、二羥基異黃酮含 量物質及自植物性蛋白質乳漿製備彼等之方法。 本發明之再進一步目標在提供配基異黃酮物質及自植物 性蛋白質乳漿製備彼等之方法。 此些和其他目標如在以下説明之本説明詳細説明中所述 地特定達成。 發明簡要 經濟部中央標準局員工消費合作社印製 本發明爲冨含配基異黃酮之植物性蛋白質乳漿及自含異 黃酮共軛物之植物性蛋白質乳漿製備富含配基異黃酮之植 物性蛋白質乳漿之方法。本方法包括將含異黃酮共軛物之 植物性蛋白質乳漿在一溫度和一 pH値下處理一段足以轉 換異黃酮共軛物成異黃酮糖苷之時間。酵素與在植物性蛋 白質乳漿之異黃酮糖答在一溫度和一 pH値下接觸一段足 以轉換大多數異黃酮糖甞成配基異黃酮之時間。 在本發明之具體實施例中,異黃酮共軛物經轉換成異黃 酮糖甞,由將植物性蛋白質乳漿。在約2 °C至約1 2 1 °C間 -8 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1241347 A7 B7 五、發明説明(6 之溫度下及在約6至约13· 7之?11値下處理。 在本發明之另-個具體實施例中,異黃嗣糖菩經轉換成 配基異黃酮,由將異黃酮糖菩與酵素在植物性蛋白質乳漿 中,在約5。(:至约75。(:㈤之溫度下及在约3至约9間之 値下接觸。 異黃明共祕至異黃嶋#及異黃至配基異黃嗣 之高轉化率經實現。在具體實施例中,至少_異黃嗣共 軏物經轉換成異黃_誓及至少8()%異黃酮糖誓經轉換成 配基異黃酮。 在另一個要素中,本發明爲配基異黃酮乳漿蛋白質物質 及自含異黃酮共耗物之植物性蛋白質乳漿製備配基異黃酮 乳漿蛋白質物質之方法。含蛋白質和配基異黃酮之配基昱 黃酮乳漿蛋白質物質係自富含配基之植物性蛋白質乳浆回 收。在本發明之具體實施例中,配基異黃嗣乳聚蛋白質物 質由至少超過濾、熱凝結和去水之一回收。在再一個要素中,本發明爲高5,7,4,_三羥基異黃酮含 量物質及自含異黃酮共軛物之植物性蛋白質乳漿製備 5,7,4'-三羥基異黃酮含量物質之方法。自植物性蛋白 乳漿衍生之配基異黃酮乳漿蛋白質物質以水性醇萃取劑萃 取,產生冨含配基異黃酮之萃取液。萃取液與吸附物質接 觸一段足以自萃取液分開高5,7,4'_三羥基異黃酮含量 質之時間。 u 在另一個要素中,本發明之高7,4,_二羥基異黃酮含 物質及自含異黃酮共軛物之植物性蛋白質乳裝製^ it 質 萃 物 量 高V. Description of the invention (4) 5,7,4'-trihydroxy isoflavones have the above formula, where Ri = 0h, R2 = h, R3 = OH and R4 = 0H, 7,4'_dihydroxy isoflavones With the above formula, where Ri = OH, R2 = H, R3 = H and R4 = 0H, and 6-methoxy_7 4, dihydroxy isoflavones have the above formula, where ri = 0h, r2 = 0ch3 , = R4 = 0H 0 Therefore, the present invention relates to the enrichment of ligands and vegetable protein milks and milk protein materials with these compounds, and particularly high content of 5, 7, 4 triseptyl isoflavones , High 7, V-dihydroxy content substances and aglycone isoflavone substances. The invention also relates to the production of algae-rich plant-based protein milk, algae-rich plant-based milk protein material, high 5,7,4 ^ trihydroxy isoflavone content material, high 7,4, dihydroxy Method of isoflavone substance and aglycone isoflavone substance. The common method for printing and converting plant protein isoflavone conjugates to aglycone isoflavones by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economics is known and provided in co-examined US patent application serial number 08 / 477,102 '1995 Apply on June 7 and be owned by the assignee of this specification. Methods for converting isoflavone glycosides to aglycone isoflavones are also known. The method for converting isoflavone glycosides to aglycone isoflavones in vegetable protein milk is provided in a co-trial application PCT / US / 94/10699, which is owned by the assignee of this specification. Other methods of converting isoflavone glycosides to aglycone isoflavones are also known in the art, as described in Japanese Patent Application No. 2 5 8, 6 6 9 and 0 b at a et al. This method does not provide the conversion of isoflavone conjugates to aglycone isoflavones or a substance with a high 5,7,4'-trihydroxy isoflavone content, a substance with a high 7,4f-dihydroxy isoflavone content or an aglycone isoflavone. Furthermore, these only reach the standard of converted sugar paper which is applicable to the Chinese National Standard (CNS) A4 specifications (210X297 mm), mouth 41347 A7 B7 grams, invention description (5 moderate degree of substitution with ligands, and the time required to substantiate In order to complete this intermediate process, JKmg this method is not required for a large number of commercial operations. This method is aimed at providing plant protein milks rich in aglycone isoflavones and preparation from plant protein milks Their method. A further object of the present invention is to provide a ligand isoflavone milk protein material and a method for preparing them from a plant-based protein milk. A still further object of the present invention is to provide a high 5,7,4, _II Hydroxyl isoflavone content materials and methods for preparing them from plant protein milk slurry. A still further object of the present invention is to provide high 7,4, dihydroxy isoflavone content materials and methods for preparing them from vegetable protein milk slurry. A still further object of the present invention is to provide a ligand isoflavone substance and a method for preparing them from a vegetable protein milk slurry. These and other objects are described in detail in the description below Brief description of the invention. Brief description of the invention. Brief summary of the invention. Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. The present invention is a plant protein milk slurry containing aglycone isoflavones and a plant protein milk slurry containing isoflavone conjugates. Method for phytoprotein milk based on isoflavones. The method includes treating a phytoprotein milk containing isoflavone conjugates at a temperature and a pH for a period sufficient to convert the isoflavone conjugates to isoflavone glycosides. Time. Enzymes are contacted with isoflavone sugars in vegetable protein milk at a temperature and at a pH for a period of time sufficient to convert most isoflavone sugars to aglycone isoflavones. In a specific embodiment of the present invention The isoflavone conjugate is converted into isoflavone glycocalyx, which is made from plant protein milk. Between about 2 ° C and about 1 2 1 ° C -8-This paper size applies Chinese National Standard (CNS) A4 specifications (210X297 mm) 1241347 A7 B7 V. Description of the invention (Processed at a temperature of 6 and at a temperature of about 6 to about 13.7 to 11 ° C. In another specific embodiment of the present invention, Isoflavone sugar Converted into Isoflavones are obtained by contacting isoflavone saccharin with enzymes in a vegetable protein milk slurry at a temperature of about 5. (: to about 75. (: ㈤) and at a temperature between about 3 to about 9. Iso黄 明 共 秘 至 异 黄 嶋 # and the high conversion rate of the isotope to the isoflavones are achieved. In a specific embodiment, at least _isohuang 嗣 conjugates are converted to 黄 yellow _ oath and at least 8 () % Isoflavone sugar is converted into aglycone isoflavones. In another element, the present invention is to prepare aglycone isoflavone milk for aglycone isoflavone milk protein material and a vegetable protein milk containing isoflavone co-consumers. Method for pulping proteinaceous materials. The aglycone flavonoid milky protein material containing protein and aglycone isoflavones is recovered from the agar-rich plant protein milk. In a specific embodiment of the present invention, the aglycone isatimilumin milk polyprotein material is recovered by at least one of ultrafiltration, thermal coagulation, and dehydration. In yet another element, the present invention is a high 5,7,4, _ trihydroxy isoflavone content substance and a 5,7,4'-trihydroxy isoflavone content prepared from a plant protein milk slurry containing an isoflavone conjugate. Material methods. The aglycone isoflavone serum protein material derived from the vegetable protein serum is extracted with an aqueous alcohol extractant to produce an aspirin-containing isoflavone extract. The extract is in contact with the adsorbed substance for a period of time sufficient to separate the extract from the extract with a high 5,7,4'_trihydroxy isoflavone content. u In another element, the high 7,4, _dihydroxy isoflavone-containing substance and the isoflavone conjugate-containing vegetable protein milk of the present invention are high in the content of the extract.

I___ - 9 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 1241347 A7 B7 五、發明説明(7 ) 7,4、二羥基異黃酮含量物質之方法。自植物性蛋白質乳 椠衍生之配基異黃酮乳漿蛋白質物質以水性醇萃取劑萃 取’產生冨含配基異黃酮之萃取液。萃取液與吸附物質接 觸一段足以自萃取液分開高7,4 '-二羥基異黃酮含量物質 之時間。 在再一個要素中,本發明爲配基異黃酮物質及自包括異 黃酮共軛物之植物性蛋白質乳漿製備配基異黃酮物質之方 法。自植物性蛋白質乳漿衍生之配基異黃酮乳漿蛋白質物 質以水性醇萃取劑萃取,產生富含配基異黃酮之萃取液。 萃取液經濃縮至其原來體積之約丨5 %至約3 〇 %間,及配 基異黃酮物質自萃取液由添加水至萃取液沈澱。 在具體實施例中,高5,7,4、三羥基異黃酮含量物質係 自配基異黃酮物質分開。配基異黃酮物質在醇水溶液中溶 劑溶合,及醇水溶液與吸附物質接觸一段足以分開高 5,7,4、三經基異黃酮含量物質之時間。 經濟部中央標準局員工消費合作社印製 在另一個具體實施例中,高7,4,_二羥基異黃酮含量物 質係自配基異黃酮物質分開。配基異黃酮物質在醇水溶液 中溶劑溶合,及醇水溶液與吸附物質接觸一段足以分開高 7,4、二輕基異黃酮含量物質之時間。 較佳具體實施例之説明 本發明之起始物爲植物性蛋白質乳漿,其中植物性蛋白 質乳漿係界定爲在自植物性蛋白質萃取液除去植物性蛋白 貧廣疋塊後剩餘之可;谷性蛋白質、異黃酮或其他水溶性化合 物之水溶液。在較佳之具體實施例中,起始物爲黃豆乳 -10-I___-9-This paper size applies the Chinese National Standard (CNS) A4 (210 X 297 mm) 1241347 A7 B7 V. Description of the invention (7) 7,4, Dihydroxy isoflavone content method. A vegetable isoflavone-derived aglucone isoflavone serum protein material was extracted with an aqueous alcohol extractant to produce an aglucone isoflavone-containing extract. The extract is contacted with the adsorbed substance for a period of time sufficient to separate the substance with a high 7,4'-dihydroxy isoflavone content from the extract. In yet another element, the present invention is a ligand isoflavone substance and a method for preparing a ligand isoflavone substance from a vegetable protein milk slurry including an isoflavone conjugate. The aglycone isoflavone serum protein material derived from the vegetable protein milk slurry is extracted with an aqueous alcohol extractant to produce an aglycone isoflavone-rich extract. The extract is concentrated to about 5% to about 30% of its original volume, and the isoflavone substance is precipitated from the extract by adding water to the extract. In a specific embodiment, the substances with a high content of 5, 7, 4, and trihydroxy isoflavones are separated from the ligand isoflavones. The ligand isoflavone substance is dissolved in the alcohol solution, and the alcohol solution is in contact with the adsorbed substance for a period of time sufficient to separate the substances with a high content of 5,7,4, and tribasic isoflavones. Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs. In another specific embodiment, the substances with high 7,4, _dihydroxy isoflavone content are separated from the aglycone isoflavone substance. The ligand isoflavone substance is solvent-soluble in an aqueous alcohol solution, and the alcohol aqueous solution is brought into contact with the adsorbed substance for a period of time sufficient to separate a substance having a high content of 7,4, dilight isoflavone. Description of a preferred embodiment The starting material of the present invention is a plant-based protein milk slurry, wherein the plant-based protein milk is defined as the remaining amount after removing the plant protein-depleted mass from the plant-based protein extract; Aqueous protein, isoflavones or other water-soluble compounds. In a preferred embodiment, the starting material is soybean milk -10-

1241347 A7 B7 五、發明説明(8 槳’因爲本發明特別適合自黃豆物質產生冨含配基異黃_ 之乳漿、配基異黃嗣乳漿蛋白質物質、高5,7,4 ’ -三起基 異黃酮含量物質、高7,4、二羥基異黃酮含量物質和配基 異黃酮物質。 植物性蛋白質乳漿起始物含異黃酮共軛物、異黃酮糖芬 和配基異黃酮。例如黃豆乳漿含··異黃酮糖甞_ 5,7,4 , _二 羥異黃酮糖:y:、7,4,-二羥基異黃酮糖甞和6_甲氧基_ 7’4 - 一每基異貰酮糖替;異黃酮共軏物_5,7,4’-三輕基 異黃酮糖甞、7,4'-二羥基異黃酮糖甞和6_甲氧基_7,4,_ 一羥基異黃酮糖甞之6〃 -丙二酸酯及5,7,4、三羥基異黃酮 糖甞和7,4、二喪基異黃酮糖苷之6〃_乙酸酯;及配基異黃 酮_5,7,4、三羥基異黃酮、7,4、二羥基異黃酮和6_甲氧 基7,4、二羥基異黃酮。在黃豆乳漿起始物中之異黃酮優 勢地爲異黃酮共軏物。 經濟部中央標準局員工消費合作社印製 、植物性蛋白質乳漿起始物典型地可以傳統植物性蛋白質 分離物生產過程之副產物獲得。植物性蛋白質源如黃豆 片自其中油已由落劑萃取除去,可以水性萃取劑共同處 理,=具高於植物性蛋白質源之蛋白質等電點之pH,以 產生各蛋白質、異黃酮和自植物性蛋白質源由萃取液溶化 2他化合物之萃取液。萃取液與不溶於萃取液之植物性 :二分開。含溶化蛋白質和異黃酮之生成萃取液之印然 至約蛋白質之等電點,黃豆蛋白質約(4-4.6,以 蛋::液沈澱蛋白質。沈澱之蛋白質經分開產生植物性 貝为離物,冑下植物性乳漿起始⑼〇大_分之異黃酮 1241347 A7 __________ B7 五、發明説明(9 ) 保持’谷於礼漿中。爲最化在乳漿中之異黃酮回收,沈澱蛋 白質I附加清洗可爲需要的,而各清洗液經加入乳漿中。 植物性蛋白質乳漿起始物可噴霧乾燥在水中漿化之植物 &蛋白%礼漿。爲各處理,植物性蛋白質乳漿可經噴霧乾 燥以回收乳漿蛋白質(在沈澱蛋白質分離物後仍溶於乳漿 <蛋白、),異黃酮和其他化合物爲固體物質。噴霧乾燥 之物貝可加入水中以還原植物性蛋白質乳漿起始物。在較 f之具體實施例中,漿每100克水含約2-10克喷霧乾燥物 處以確遇礼裝不太稠,而提供足夠之異黃酮以產生所要之 田含配基異黃酮之乳漿、配基異黃酮乳漿蛋白質物質、高 5’7,4 -二羥基異黃酮含量物質、高7,4,-二羥基異黃酮含 量物質和配基異黃酮物質。 在第1個轉化步驟或操作中,在植物性蛋白質乳漿起始 $中<異黃綱共軛物經轉換成異黃酮糖甞,以產生富含異 更酮糖甞之植物性蛋白質乳漿。轉化經發現依乳漿之pH 和溫度而定。 經濟部中央標準局員工消費合作社印製 轉化異黃_共軛物成異黃酮糖甞之pH範圍爲自約6至約 1 3 · 5。植物性蛋白質乳漿之ρ η應在需要在時調至所要之 ΡΗ。黃昱蛋白質乳槳典型地具約4· 4-4.6之pH値及應以 鹼或鹼性試劑調至所要之pH範圍。pH可以任何合適之 鹼、苛性劑或鹼性試劑調整,其將增加系統之pH,包括 氯氧化納、氫氧化鉀和氫氧化鈣。轉化經發現在極強鹼性 條作下更易進行,較佳地9-1 1。pH應維持低於pH 12, 因爲異黃綱糖苷7,4'-三羥基異黃酮糖:y:、7, 二羥1241347 A7 B7 V. Description of the invention (8 oars' because the present invention is particularly suitable for the production of an isoflavone-containing cream from a soybean material, an isoflavone cream protein material, a high 5,7,4'-three Starting material isoflavone content, high 7,4, dihydroxy isoflavone content material and aglycone isoflavone material. The plant protein milk starter contains isoflavone conjugate, isoflavone saccharin and aglycone isoflavone. For example, soymilk contains isoflavone sugar 甞 5,7,4, _ dihydroxy isoflavone sugar: y :, 7, 4, 4-dihydroxy isoflavone sugar 甞 and 6_methoxy _ 7'4- Isoflavone sugar replacement per base; isoflavone conjugates_5,7,4'-trisyl isoflavone glycosides, 7,4'-dihydroxy isoflavone glycosides and 6_methoxy_7, 6〃-malonic acid esters of 4, _ monohydroxy isoflavone glycosides and 5,7,4,6〃-acetates of trihydroxy isoflavone glycosides and 7,4, dibenzyl isoflavone glycosides; and Ligand isoflavones_5,7,4, trihydroxy isoflavones, 7,4, dihydroxy isoflavones, and 6-methoxy 7,4, dihydroxy isoflavones. Isoflavones in soy milk starting materials Isoflavone conjugates are advantageous. Member of the Central Standards Bureau of the Ministry of Economic Affairs Printed by industrial and consumer cooperatives, plant protein milk starting materials are typically obtained as by-products of the traditional plant protein isolate production process. Plant protein sources, such as soy flakes, from which the oil has been extracted by falling agents, can be extracted by water Co-treatment with agents, = has a pH higher than the isoelectric point of the protein of vegetable protein source to produce each protein, isoflavones, and extracts of other compounds dissolved from the extract by the vegetable protein source. The extract is insoluble in the extract Liquid vegetative nature: two separate. The solubilized protein and isoflavone-containing extracts from the imprinting point to about the isoelectric point of the protein, soy protein about (4-4.6, egg :: liquid precipitates the protein. The precipitated protein is separated The production of plant-based shellfish is a separate matter, and the starting of the plant-based milk is ⑼ big _ isoflavones 1241347 A7 __________ B7 V. Description of the invention (9) Keep 'grain in the gift slurry. For the best in the slurry Isoflavone recovery, additional cleaning of precipitated protein I may be required, and each cleaning solution is added to the slurry. The vegetable protein slurry starting material can be spray-dried in water Plant & protein% gift pulp. For each treatment, the plant protein milk can be spray-dried to recover milk protein (still soluble in milk < protein, after Shendian protein isolate), isoflavones and others The compound is a solid substance. The spray-dried shellfish can be added to water to reduce the plant protein milk slurry starting material. In a more specific embodiment, the slurry contains about 2-10 grams of spray-dried material per 100 grams of water to confirm that The gift set is not too thick, but provides enough isoflavones to produce the desired isoflavone-containing isoflavone-containing milk, aglycone isoflavone milk protein material, high 5'7,4-dihydroxy isoflavone content material, High 7,4, -dihydroxy isoflavone content substances and aglycone isoflavone substances. In the first transformation step or operation, the isoflavone conjugate is converted to isoflavone glycocalyx in the plant protein milk slurry starting $ to produce isoflavone glycocalyx-rich plant protein milk Pulp. Conversion was found to depend on the pH and temperature of the slurry. Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. The pH range for converting isoflavone conjugates to isoflavone glycocalyx is from about 6 to about 13.5. The ρ η of the vegetable protein milk should be adjusted to the desired pH when needed. Huang Yu protein milk paddles typically have a pH of about 4.4-4.6 and should be adjusted to the desired pH range with an alkali or alkaline reagent. The pH can be adjusted with any suitable alkali, caustic or alkaline reagent, which will increase the pH of the system, including sodium oxychloride, potassium hydroxide and calcium hydroxide. The transformation was found to proceed more easily under extremely alkaline conditions, preferably 9-1 1. The pH should be maintained below pH 12, because isoflavone glycosides 7,4'-trihydroxy isoflavones: y :, 7, dihydroxy

1241347 A7 B7 五、發明説明(1〇 基異黃酮糖答和6 -甲氧某^ H 7,4 _二羥基異黃酮糖甞,特別 地7,4'-二羥基異黃酮糖苷一太 m ^在PH値12及以上傾向降解。 反應在較低p Η條件下較不具、隹一 Γ牧+易進行,例如約pH 6,然而, 反應將在更高溫度和/或在增加壓力下進行。 轉化異黃酮共軛物或異黃酮糖甞之溫度範圍係自約2X: 至約12 1。。。轉化易發生之溫度範圍依乳漿之pH而定。 本發明者發現轉化在pH極高時在較低溫度下易於進行。 例如,在約u之乳漿pH下,轉化在約5χ:至約5〇χ:之溫 度範圍下容易和有效地進行。在約9之乳漿?11下,轉化在 約4 5 C至約7 3 C之溫度範圍下轉化有效地發生。當乳漿 pH極低時,轉化在更高溫度下發生。例如,在6之乳漿 pH下,轉化在約8 〇。(:至約i 2丨t之溫度範圍下發生。在 較佳之具體實施例中,轉化在約3 5下在約丨丨之乳漿pH 下完成。在另一個較佳具體實施例中,轉化在約7 3在 約9之乳漿pH下完成。 實質完成轉化異黃酮共軛物成異酮糖甞之發生所需之時 段係依植物性蛋白質乳漿之p Η和溫度而定。時段範園自 15分鐘多至24小時。轉化在更高pH下和在更高溫度下更 易發生。在約9-10之pH下,轉化在73°C下在約4至約6小 時内實質地完成。在約10-11之pH下,轉化在35 °C下在 約3 0分鐘至約〗小時内實質地完成。在最佳之具體實施例 中,異黃酮共軛物在約11之pH値下和在約35°C之溫度下 在約4 5分鐘内經轉換成異黃酮糖:y:。 第一個轉化步驟係相當有效的,轉換自約8 0 %至約 -13- 本紙張尺度適用中國國家標準(Cns ) A4規格(21〇Χ297公釐) 請 先 閱 讀 背 意 事 項 Η if 經濟部中央標準局員工消費合作社印製 1241347 A7 B7 五、發明説明(12 ^佳〈具體實施例中,補充酵素經加人乳漿中, $疋α'足夠殘留酵素存在於乳漿中,因爲補充 、 戲劇性地降低進行實質完成轉化糖菩成配基所需之::加 有:充酵素基於在選定ΡΗ和溫度條件下最適活 定。補充酵素爲能裂解異黃㈣分和異黃酮㈣ 邵分間之鍵之酵素,如能裂解糖誓鍵之醣酶 Ϊί 之補充酵素爲商業來源之《和β葡萄糖芬酶 經濟部中央標準局員工消費合作社印製 '、、β_半乳糖甞酶酵素、葡萄糖澱粉酶酵素及果膠酶 酵素。特別較佳的是酵素如生物果膠酶1〇〇L (其較佳地用 在自約3至约6之pH範圍)、生物果膠酶3〇〇L(最適pH範 圍自約3至約6)、生物果膠酶〇K 7〇L(最適pH範圍自約3 至約6)、生物乳糖酶3〇,〇〇〇(最適1)11範圍自約3至約6)及 中性乳糖酶(最適pH範園自約6至约8 ),其所有自探索國 際獲得,1 8 3 3號5 7街,郵箱3 9 1 7,莎拉蘇達,佛州 3 4243。亦特別佳的是乳糖F(最適pH範圍自約4至約6) 及乳糖酶5 0,000(最適pH範圍自約4至約6),其獲自阿曼 諸國際酵素公司,郵箱1000,托伊,維吉尼亞州 22974。其他特別佳之補充酵素包括G_Zyme G990(最 適p Η自約4至約6 )和E n z e c 〇眞菌乳糖酶濃縮液(最適p Η 範圍自約4至約6),獲自酵素發展公司,2號賓廣場, 2 4 3 9 室,紐約市,紐約州 1 〇 1 2 1 ϊ Lactozyme 3 0 0 0 L (最適pH範圍自約6至約8)和a-Gal 600L (最適pH自約4 至約6.5)獲自Novo Nordisk生物工業公司,33號呑那 路,丹堡,康乃狄克州06 8 1 3 ;中性乳糖酶(最適PH範園 -15- 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇χ297公釐) 1241347 A7 B7 五、發明説明(13 ) 自約6至約8),獲自Pfizer食品科學群,205號東42街, 無約市,紐約州10017 ;及Maxilact L2000(最適pH範 圍自約4至約6 ),獲自G i s t B r 〇 c a d e s組份公司,普魯士 王,賓州1 9 4 0 6。 一旦存在足夠濃度之酵素,或自殘留酵素、補充酵素或 兩者’酵素與異黃酮核甞在乳漿中在一pH値和溫度下接 觸一段足以轉換至少大多數及較佳地實質合部異黃酮糖芬 成配基異黃酮之時間。在需要時,富含異黃酮糖甞之乳漿 之PH應調至酵素與異黃酮糖甞活性反應之pH範圍内。在 此PH範圍内,合併之殘留酵素和補充酵素與異黃酮糖甞 反應,其係自約3至約9。 本發明者發現在乳漿中殘留之酵素係有效在約7至約9 之pH範園内,因爲當然地乳漿之pH在反應過程期間係低 下。補充酵素係有效在酵素廠商所特定之最適p Η範圍, 如上述爲一些特定酵素。典型地,補充酵素係有效於自約 6至約8之中性ρ Η範圍,或於自約4至約6之酸性ρ Η範 圍。酸性酵素亦經顯示有效在約3之pH。 經濟部中央標準局員工消費合作社印製 乳漿之pH可經調整,在大部分例中自第1個步驟之極高 或驗性pH降低,由添加1或多種合適酸如乙酸、硫酸、憐 酸、鹽酸或任何合適之試劑。較佳地,使用之試劑將爲食 TO級性試劑或酸。 轉化異黃酮糖甞成配基異黃酮之溫度範圍係自約5 t至 約7 5 C。溫度顯著影響酵素活性,及因此轉化率。補充 酵素可有效高於72.5°C,例如a-Gal 600L有效在75 -16-1241347 A7 B7 V. Description of the invention (10-based isoflavone glycoside and 6-methoxy ^ H 7,4 _ dihydroxy isoflavone glycocalyx, in particular 7,4'-dihydroxy isoflavone glycoside -1 m ^ Degradation tends to be at pH 12 and above. The reaction is less likely at lower pH conditions and easier to carry out, such as about pH 6, however, the reaction will be performed at higher temperatures and / or under increased pressure. The temperature range for the conversion of isoflavone conjugates or isoflavone glycocalyx is from about 2X: to about 12 1. The temperature range in which conversion is liable to occur depends on the pH of the slurry. The inventors have found that the conversion occurs at extremely high pH It is easy to carry out at lower temperatures. For example, at a pH of the slurry of about u, the conversion is easily and efficiently performed at a temperature range of about 5x: to about 50x: at a slurry of about 9? 11, The conversion occurs efficiently at a temperature range of about 4 5 C to about 7 3 C. When the pH of the slurry is extremely low, the conversion occurs at a higher temperature. For example, at a pH of 6 of the slurry, the conversion occurs at about 8 〇. (: To a temperature range of about i 2 丨 t. In a preferred embodiment, the pH of the slurry is about 丨 丨 at about 35 Completed. In another preferred embodiment, the transformation is completed at a pH of about 7 3 at a pH of about 9. The time period required to substantially complete the conversion of the isoflavone conjugate to the isoxone glycocalyx is plant-dependent The temperature and temperature of the protein emulsion depend on the temperature. The time period ranges from 15 minutes to 24 hours. The transformation occurs more easily at higher pH and at higher temperature. At a pH of about 9-10, the transformation is at 73 ° Substantially complete in about 4 to about 6 hours at C. At a pH of about 10-11, conversion is substantially complete in about 30 minutes to about 30 hours at 35 ° C. In the best specific embodiment The isoflavone conjugate is converted to isoflavone sugars at a pH of about 11 and at a temperature of about 35 ° C in about 45 minutes: y: The first conversion step is quite effective. From about 80% to about -13- This paper size applies to the Chinese national standard (Cns) A4 specification (21〇 × 297 mm) Please read the note first Η if printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 1241347 A7 B7 V. Description of the invention (12 ^ 佳 <In the specific embodiment, supplementary enzymes are added to human milk, and $ 疋 α 'is sufficient Retaining enzymes are present in the milk because supplementation and dramatic reductions are required to substantially complete the conversion of sugar to phytophysin :: plus: Enzymes are based on optimal activity under selected pH and temperature conditions. Supplementing enzymes are capable of cleavage Isoflavones and isoflavones. The enzymes of the bond between Shaofen, such as sugar enzymes that can cleave sugar vow bonds. The supplementary enzymes are commercial sources. Β-galactosidase enzyme, glucoamylase enzyme and pectinase enzyme. Particularly preferred are enzymes such as biological pectinase 100L (which is preferably used in a pH range from about 3 to about 6) ), Biological pectinase 300L (optimal pH range from about 3 to about 6), biological pectinase OK 70L (optimal pH range from about 3 to about 6), biological lactase 3,0. 〇〇 (optimum 1) 11 ranges from about 3 to about 6) and neutral lactase (optimal pH Fanyuan from about 6 to about 8), all of which are obtained from Discovery International, 1 8 3 3 5 7th Street, mailbox 3 9 1 7, Sarasota, Florida 3 4243. Also particularly preferred are lactose F (optimal pH range from about 4 to about 6) and lactase 5 0,000 (optimal pH range from about 4 to about 6), which are obtained from Oman International Enzyme Company, mailbox 1000, TOY, Virginia 22974. Other particularly good supplementary enzymes include G_Zyme G990 (optimum p 约 from about 4 to about 6) and Enzec 〇 眞 bacteria lactase enzyme concentrate (optimal p Η range from about 4 to about 6), obtained from the enzyme development company, No. 2 Bin Plaza, Room 2 4 3 9, New York City, New York 1 〇 1 2 1 ϊ Lactozyme 3 0 0 0 L (optimal pH range from about 6 to about 8) and a-Gal 600L (optimal pH from about 4 to about 6.5) Obtained from Novo Nordisk Bio-Industrial Corporation, No. 33, Janna Road, Danbourg, Connecticut 06 8 1 3; Neutral lactase (best pH range Fan-15-This paper size applies to Chinese national standards (CNS ) A4 size (21 × 297 mm) 1241347 A7 B7 V. Description of the invention (13) from about 6 to about 8), obtained from Pfizer Food Science Group, 205 East 42nd Street, Wuyue City, New York 10017; and Maxilact L2000 (the optimal pH range is from about 4 to about 6), obtained from Gist Br cades component company, King of Prussia, Pennsylvania 1940. Once a sufficient concentration of enzyme is present, or from residual enzymes, supplementary enzymes, or both, the enzyme and the isoflavone core are contacted in the milk at a pH and temperature for a period sufficient to convert at least most and preferably substantially heterozygous Time of flavonoid saccharin to aglycone isoflavone. When needed, the pH of the isoflavone glycocalyx-rich milk should be adjusted to a pH range where the enzyme reacts with the isoflavone glycocalyx. Within this pH range, the combined residual and supplementary enzymes react with the isoflavone glycocalyx from about 3 to about 9. The inventors have found that the enzymes remaining in the milk are effective in a pH range of about 7 to about 9, because of course, the pH of the milk is low during the reaction process. Supplementary enzymes are effective in the optimal pH range specified by enzyme manufacturers, as mentioned above for some specific enzymes. Typically, supplemental enzymes are effective in the neutral pH range from about 6 to about 8, or in the acidic pH range from about 4 to about 6. Acid enzymes have also been shown to be effective at a pH of about 3. The pH of the cream produced by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs can be adjusted. In most cases, the pH from the first step is extremely high or the pH is reduced. Acid, hydrochloric acid or any suitable reagent. Preferably, the reagents used will be food grade reagents or acids. The temperature range for conversion of isoflavone glycosides to aglycone isoflavones ranges from about 5 t to about 7 5 C. Temperature significantly affects enzyme activity and therefore conversion. Supplement enzymes can be effective above 72.5 ° C, for example, a-Gal 600L is effective at 75 -16-

1241347 Α7 Β7 五、發明説明(14 ) c ’然而較佳地在較低溫度下進行轉化,以防止酵素去活 性化。在較佳具體實施例中,轉化在約3 5至約4 5 π間 完成。 較佳地’酵素反應在如第1個轉化步驟之相同溫度下進 行,因而消除在第1個轉化步驟後改變乳漿溫度之必要 性。最佳地,第2個轉化步驟及第1個轉化步驟皆在3 5 〇c 下進行。 亦較佳地,固定溫度在轉化異黃酮糖菩至配基異黃酮 之全程維持著。然而’在一些例中,可必要地升高、降 低或者是改變在反應過程期間之溫度。 弟2個轉化步驟所要之時段依酵素有關之因子而定,特 別地;辰度及乳漿之溫度和p Η。在大部分例中,可能地在 2 4小時内達成完全轉化,然而,較佳地補充酵素經加入 以戲劇性地增加反應速率。選定之補充酵素、酵素濃 度、pH和溫度較佳地導致在2小時内實質完全轉化,及 最佳地在1小時内。 經濟部中央標準局員工消費合作社印製 在第2個轉化步驟中轉化異黃酮糖苷至配基異黃酮之程 度係顥著的,典型地自至少約8 〇 %至i 〇 〇 %。至少9 5 % 異更酮糖答轉化成配基異黃酮通常經達成。 轉化異更酮糖嘗成配基異黃酮後,富含配基異黃酮之 乳漿可如所要地採用’而無乾燥或除去乳漿中之蛋白 質’或可替代地配基異黃酮乳漿蛋白質物質可經回收以 濃縮在蛋白質物質中之配基異黃酮。配基異黃酮乳漿蛋 白質物質,如在此所用,係界定爲含蛋白質、配基異黃 _·17_ 本紙張尺度適用中國國家標準(CNS ) Α4規格(21 ΟΧ 297公釐) 1241347 A7 五、發明説明(15 ) 酮和可自植物性蛋白質乳漿沈澱和分開之殘留植物性化 合物I物質。冨含配基異黃酮之蛋白質物質可由傳統程 序如超過濾、熱凝結和去水回收。生成之配基異黃酮乳 漿蛋白質物質可由傳統方法去水和乾燥。 配基異黃酮乳漿蛋白質物質亦可自乳漿由冷卻乳漿回 收。配基異黃酮乳漿蛋白質物質不溶於冷卻之乳漿及可 以沈澱物自乳漿由離心冷卻乳漿分開。較佳地,乳漿經 冷至約4 °C以沈澱蛋白質物質。 在較佳之具體實施例中,乳漿經濃縮以增強配基異黃 酮乳漿蛋白質物質之回收。頃發現由濃縮乳漿增加在乳 漿中固形物對液體比値增加配基異黃酮乳漿蛋白質物質 自乳漿之捕獲。乳漿可由加熱,置乳漿於減壓下或兩者 濃縮。較佳地,乳漿經濃縮至約1 : 3至約1 : 6之固形物 對液體比値,最佳地約1 : 3。 高5,7,4、三羥基異黃酮含量物質和高74、二羥基異黃 酮含量物質可自回收之配基異黃酮乳漿蛋白質物質產生。 如在此所用,高5,7,4、三羥基異黃酮含量物質係界定爲 含至40%5,7,4、三經基異黃酮及最佳地至少9〇%5,7 4,_ 經濟部中央標準局員工消費合作社印製 三經基異黃黃酮與殘留植物性物質一起之植物性物質,其 在南5,7,4f_二髮基異黃酮含量物質係自黃豆乳漿回收 時,爲殘留黃豆物質。高7,4、二羥基異黃酮含量物質含 至少4 0 % 7,4、二羥基異黃酮以及殘留植物性物質。 爲產生高5,7,4'-三羥基異黃酮和高7,4、二羥基異黃明 含量物質’配基異黃酮乳漿蛋白質物質最初經清洗以除去 ______18_ 本紙張又度適用中國國家標準(CNS ) A4規格(2丨0'乂297公釐) ' — 1241347 A7 B7 五、 發明説明( 16 經濟部中央標準局員工消費合作社印製 不想要之鹽和糖及然後乾燥。爲清洗配基異黃酮乳漿蛋白 質物質,物質以水稀釋,較佳地至約1 0/〇固形物至約6 〇/〇固 形物,及最佳地至約2 %固形物。清洗水可爲任何溫度 的’然而較佳地在約2 5 Ό至約7 5 °C間,及最佳地約6 0 C。清洗配基異黃_乳漿蛋白質物質後,物質自清洗液分 開及乾燥。在較佳之具體實施例中,物質由離心物質及自 物質傾倒上清液分開。 配基異黃酮乳漿蛋白質物質然後可以水性醇萃取劑萃 取,以自乳漿蛋白質除去配基異黃酮及產生富含配基異黃 酮之萃取液。低分子量醇如甲醇及特別地乙醇係較佳地作 爲萃取劑之醇成份。配基異黃酮經發現溶於幾乎全部醇濃 度之萃取劑。配基異黃酮特別可溶在萃取劑含約3 〇 %醇至 約9 0 %醇間,最佳地在約6 〇 0/❶醇至約8 〇 %醇間。雖然水 性醇爲較佳之溶劑,其他溶劑包括水、乙腈、二氯甲烷、 丙酮和乙酸乙酯及此些溶劑之混合液可用以完成配基異黃 酮自乳漿蛋白質物質之萃取。 萃取使用最小量之萃取劑進行。較佳地,萃取劑對配基 異黃酮乳漿蛋白質物質之重量比値不超過u :丨。在具體 實施例中,物質使用逆流萃取過程萃取,其中萃取劑對物 質灸重量比値在約6 : 1至約8 :丨間。在另一個具體實施 例中,物質可以2部分萃取劑萃取,其中萃取劑對物質之 合併重量比値不超過1 i : i。 雖然萃取可在任何pH下進行,較佳地萃取劑具在配基 異黃酮乳漿蛋白質物質中約蛋白質等電點ipH。以最小 (請先閱讀背面之注意事項再填寫本頁)1241347 Α7 Β7 V. Description of the invention (14) c 'However, it is preferable to perform transformation at a lower temperature to prevent deactivation of the enzyme. In a preferred embodiment, the conversion is between about 35 and about 45 π. Preferably, the 'enzyme reaction is performed at the same temperature as in the first conversion step, thereby eliminating the need to change the temperature of the slurry after the first conversion step. Optimally, both the second transformation step and the first transformation step are performed at 3 5c. Also preferably, the fixed temperature is maintained throughout the conversion of the isoflavone saccharin to aglycone isoflavone. However, in some cases, it may be necessary to raise, lower, or change the temperature during the reaction. The time required for the two transformation steps depends on the factors related to the enzyme, in particular; the temperature and the temperature and pΗ of the milk. In most cases, complete conversion is likely to be achieved within 24 hours, however, it is preferred that supplementary enzymes be added to dramatically increase the reaction rate. The selected supplementary enzyme, enzyme concentration, pH, and temperature preferably result in substantially complete conversion within 2 hours, and optimally within 1 hour. Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs The degree of conversion of isoflavone glycosides to aglycone isoflavones in the second conversion step is significant, typically from at least about 80% to 100%. Conversion of at least 95% isoglucanose to aglycone isoflavones is usually achieved. After the isoglucan sugar is converted to aglycone isoflavones, the aglycone isoflavone-rich milk can be used as desired 'without drying or removing proteins in the milk' or alternatively aglycone isoflavone milk proteins The material may be recovered to concentrate aglycone isoflavones in the protein material. Aglycone isoflavone milk protein material, as used herein, is defined as protein-containing, aglycone isoflavones. ·· 17_ This paper size applies the Chinese National Standard (CNS) A4 specification (21 〇 × 297 mm) 1241347 A7 V. Description of the invention (15) Ketones and residual plant compound I substances that can be precipitated and separated from vegetable protein milk slurry.配 Protein materials containing aglycone isoflavones can be recovered by conventional procedures such as ultrafiltration, thermal coagulation, and dehydration. The resulting aglycone isoflavone serum protein material can be dewatered and dried by conventional methods. The aglycone isoflavone serum protein material can also be recovered from the cooling slurry from the slurry. The aglycone isoflavone milk protein material is insoluble in the cooled milk and the precipitate can be separated from the milk by centrifugal cooling. Preferably, the slurry is cooled to about 4 ° C to precipitate proteinaceous matter. In a preferred embodiment, the slurry is concentrated to enhance the recovery of proteinaceous material of the isoflavone slurry. It was found that increasing the concentration of solids to liquid ratio in the milk by concentrated milk increased the capture of aglycone isoflavone milk protein protein from the milk. The slurry can be heated and concentrated under reduced pressure or both. Preferably, the slurry is concentrated to a solid to liquid ratio of about 1: 3 to about 1: 6, most preferably about 1: 3. Substances with a high 5,7,4, trihydroxy isoflavone content and substances with a high 74, dihydroxy isoflavone content can be produced from the recovered isoflavone serum protein material. As used herein, substances with a high 5,7,4, trihydroxy isoflavone content are defined as containing up to 40% 5,7,4, trisyl isoflavones and optimally at least 90% 5,7 4, _ The plant-based substance of Sanjingji Isoflavones and residual plant substances printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs. , Residual soy material. High 7,4, dihydroxy isoflavone content substances contain at least 40% 7,4, dihydroxy isoflavones and residual plant matter. In order to produce high 5,7,4'-trihydroxy isoflavones and high 7,4, dihydroxy isoflavin content substances, the aglycone isoflavone milk protein material was initially washed to remove ______18_ This paper is again suitable for China Standard (CNS) A4 specification (2 丨 0 '乂 297 mm)' — 1241347 A7 B7 V. Description of the invention (16 Employees' cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs print undesired salts and sugars and then dry them. For cleaning Base isoflavone serum protein material, the material is diluted with water, preferably to about 10/0 solids to about 60/0 solids, and most preferably to about 2% solids. The washing water can be at any temperature However, it is preferably between about 25 ° F. and about 75 ° C., and most preferably about 60 ° C. After washing the isoflavone_milk protein material, the material is separated from the cleaning solution and dried. In a preferred embodiment, the substance is separated by centrifuging the substance and the supernatant from which the substance is poured. The aglycone isoflavone serum protein material can then be extracted with an aqueous alcohol extractant to remove the aglycone isoflavones from the milk protein and produce a rich formula Isoflavone extracts. Low molecular weight alcohols such as methanol In particular, ethanol is preferred as the alcohol component of the extractant. Aglycone isoflavones have been found to dissolve in almost all alcohol concentration extractants. Aglycone isoflavones are particularly soluble in the extractant and contain about 30% alcohol to about 90 % Alcohol, most preferably between about 600% methanol and about 80% alcohol. Although aqueous alcohols are the preferred solvents, other solvents include water, acetonitrile, dichloromethane, acetone, and ethyl acetate and these The solvent mixture can be used to complete the extraction of aglycone isoflavones from the serum protein material. The extraction is performed using a minimum amount of extractant. Preferably, the weight ratio of the extractant to the aglycone isoflavones protein material does not exceed u : 丨. In a specific embodiment, the substance is extracted using a countercurrent extraction process, wherein the weight ratio of the extractant to the substance moxibustion is between about 6: 1 to about 8: 丨. In another embodiment, the substance can be extracted in 2 parts Extraction, where the combined weight ratio of extractant to substance 値 does not exceed 1 i: i. Although the extraction can be performed at any pH, it is preferred that the extractant has about the isoelectric point of the protein in the isoflavone slurry protein material ipH. with minimal (Please read the notes on the back before filling this page)

、1T • i^n In m n - I—- 1------ -19- 1241347 A7 一~— ----~— B7 五、發明説明(17 ) 化在萃取劑中蛋白質之溶解度。較佳地,萃取劑具在约3 至約6間&lt;PH値及最佳地約45,在乳漿蛋白質 漿蛋白質。 % 萃取可在任何溫度,多至萃取劑之沸點下進行,及較佳 地在约2 5 C至約7 0 C間進行。爲降低自配基異黃酮乳漿 蛋白質物質萃取配基異黃酮之時間,較佳地在升高過室= 之溫度下’最佳在約6 〇 下進行萃取。 萃取後,高5,7,4'-三羥基異黃酮含量物質和高7,4、二 羥基異黃酮含量物質可自富含配基異黃酮之萃取液分開, 由萃取液與吸附物質接觸一段足以自萃取液分開高 5,7, V-三羥基異黃酮和高74、二羥基異黃酮含量物質之 時間。在較佳之具體實施例中,高5,7,4、三羥基異黃酮 和高7, V-二羥基異黃酮含量物質係自萃取液由逆相高效 液相層析法(“HPLC”)分開。5,7,4、三羥基異黃酮和 7,4、二羥基異黃酮自其他異黃酮和不純物在萃取液中分 開,由溶析萃取液經吸附物質之粒子,其可釋放地以一種 化合物特定方式結合5,7,4、三羥基異黃酮、74,_二藉基 異黃酮、其他異黃酮及不純物,因而能使各化合物被分開。 經濟部中央標準局員工消費合作社印製 富含配基異黃酮之萃取液先經過濾以除去不溶性物質及 可接上HPLC管柱。HPLC管柱由填充傳統商業獲得 HPL C管柱以粒狀吸附物質製備,將可釋放地以一種化合 物特定方式結合5,7,4、三羥基異黃酮、74\二經基異黃 酮、其他異黃酮和不純物。吸附物質可爲任何逆相HPLC 填充物質,然而,較佳之填充物質可由裝載容量、分離效 -20- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 1241347 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(18 力和成本之標準選定。—種如此之較佳填充物質爲 Kromasil C18 16微米100埃珠,獲自伊卡。諾貝爾, 諾貝爾工業,瑞典。 過濾之萃取液通過填充之HPLC管柱,直至所有管柱之 結合部位全然以異黃酮飽和,其由自管柱之流出液中里黃 酮外觀檢測。HPLC管柱然後可以極性溶析液溶析以完成 分開。在較佳之具體實施例中,溶析液爲水性醇。水性醇 溶析液可具約30%至約90%醇間之醇含量,及較佳地具 約50%醇之醇含量,以提供異黃醇之良好分開和良好溶解 度。醇較佳地爲甲醇或乙醇,其中乙醇是較佳地,當高 5,7,4,-三羥基異黃酮或高7 4,·二羥基異黃酮含量產品物 質要用於食品或藥物應用。 高5,7,4'-三羥基異黃酮和高74、二羥基異黃酮含量物 質係自管柱流出液收集。含7,二羥基異黃酮之流出液 區分先自管柱落析,接著6 -甲氧基_7,4,_二羥基異黃酮區 分液,其後接著更極性之5,7,4、三羥基異黃酮區分液。 7,4'-二羥基異黃酮和5,7,4,_三羥基異黃酮區分液如其自 管柱溶析地收集。6 -甲氧基-7,4、二羥基異黃酮區分液在 想要時亦可收集。 在區分液中之醇可由蒸發除去,其後高5,7,4乂三羥基 異黃酮1和高7,4’ -二羥基異黃酮含量物質及高6_甲氧基-7,4、一每基異黃_含量物質可由傳統分離方法如離心或 過滤回收。回收之高5,7,4三羥基異黃酮含量物質含至 少40。/〇5,7,4、三羥基異黃酮及較佳地至少90%5 7 4、三 -21 - μ氏張尺度適用中國國家標準(CNS ) a4規格(210X297公釐), 1T • i ^ n In m n-I—- 1 ------ -19- 1241347 A7 A ~ — ---- ~ — B7 5. Description of the invention (17) The solubility of the protein in the extractant. Preferably, the extractant has between about 3 to about 6 &lt; PH &gt; and most preferably about 45, in the milk protein protein. % Extraction can be performed at any temperature up to the boiling point of the extractant, and preferably between about 25 ° C and about 70 ° C. In order to reduce the time required for the extraction of aglycone isoflavones from the protein substance of the aglycone isoflavone slurry, it is preferable to perform the extraction at a temperature of about 60 ° C, preferably at about 60 ° C. After extraction, substances with high content of 5,7,4'-trihydroxy isoflavones and substances with high content of 7,4 and dihydroxy isoflavones can be separated from the extraction solution rich in aglycone isoflavones. Time sufficient to separate 5,7, V-trihydroxy isoflavones and 74, dihydroxy isoflavones from the extract. In a preferred embodiment, the substances with high 5,7,4, trihydroxy isoflavones and high 7, V-dihydroxy isoflavones are self-extracted and separated by reverse phase high performance liquid chromatography ("HPLC"). . 5,7,4, trihydroxy isoflavones and 7,4, dihydroxy isoflavones are separated from other isoflavones and impurities in the extraction solution, and the particles of the adsorbed substance are dissolved by the extraction solution, which are releasably specified by a compound The method combines 5,7,4, trihydroxy isoflavones, 74, -dityl isoflavones, other isoflavones and impurities, so that the compounds can be separated. Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs, the aspirin-rich isoflavone-rich extract was filtered to remove insoluble materials and connected to HPLC columns. HPLC columns are prepared by filling traditional commercial-obtained HPL C columns with granular adsorbed substances, which releasably bind 5,7,4, trihydroxy isoflavones, 74 \ dionyl isoflavones, and other isomeric compounds in a specific way. Flavonoids and impurities. The adsorbent can be any reverse-phase HPLC filling material. However, the preferred filling material can be loaded with capacity and separation efficiency. -20- This paper size applies to China National Standard (CNS) A4 (210X 297 mm). 1241347 Central Bureau of Standards, Ministry of Economic Affairs Printed by employee consumer cooperative A7 B7 V. Description of invention (18 Force and cost criteria selected.-A better filling material of this kind is Kromasil C18 16 micron 100 Angstrom beads, obtained from Ika. Nobel, Nobel Industries, Sweden The filtered extract was passed through a packed HPLC column until the binding sites of all the columns were completely saturated with isoflavones, which was detected by the appearance of flavonoids in the effluent from the column. The HPLC column can then be eluted with a polar eluent to The separation is completed. In a preferred embodiment, the eluate is an aqueous alcohol. The aqueous alcohol eluate may have an alcohol content between about 30% and about 90% alcohol, and preferably an alcohol content of about 50% alcohol In order to provide good separation and good solubility of isoflavones, the alcohol is preferably methanol or ethanol, of which ethanol is preferred, when high 5,7,4, -trihydroxy isoflavones or high 7 4, · dihydroxy Isoflavones Content product substances are to be used in food or pharmaceutical applications. High 5,7,4'-trihydroxy isoflavones and high 74, dihydroxy isoflavone content substances are collected from the column effluent. Outflow containing 7, dihydroxy isoflavones The liquid separation was first separated from the column, followed by the 6-methoxy-7,4, _dihydroxy isoflavone separation solution, followed by the more polar 5,7,4, and trihydroxy isoflavone separation solution. 7,4 '-Dihydroxy isoflavones and 5,7,4, _trihydroxy isoflavone fractions are collected as they elute from the column. 6-methoxy-7,4, dihydroxy isoflavone fractions are also available when desired. Can be collected. The alcohol in the separation liquid can be removed by evaporation, and then high 5,7,4 乂 trihydroxy isoflavone 1 and high 7,4'-dihydroxy isoflavone content and high 6_methoxy-7, 4. A substance with an isoflavone content can be recovered by traditional separation methods such as centrifugation or filtration. The recovered content of 5,7,4 trihydroxy isoflavones contains at least 40./05,7,4, trihydroxy isoflavones. And preferably at least 90% 5 7 4, 3-21-μ's scale is applicable to Chinese National Standard (CNS) a4 specifications (210X297 mm)

1241347 A71241347 A7

五、發明説明(19 ) 羥基異黃酮,與殘留之植物性物質一起,其在5,7,4、三 羥基異黃酮係自黃豆乳漿回收時,爲殘留黃豆物質。回收 &lt;高7,4 '-二輕基異黃酮含量物質含至少4 〇 % 7,4、二羥基 異贡酮,與殘留植物性物質一起,其典型地包括顯著量之 甲氧基-7,4、二魏基異黃_。 在本發明之另一個具體實施例中,配基異黃酮物質係自 S含配基異黃酮之萃取液產生。如在此所用,配基異黃酮 物質係界定爲含至少1 〇 % 5,7,4 三羥基異黃酮和至少 5 % 7,4、二經基異黃酮以及其他異黃酮和殘留植物性化合 物之物質。 配基異黃酮乳漿蛋白質物質之萃取後,富含配基異黃酮 之萃取液可經濃縮以促進配基異黃酮自萃取液之沈澱。萃 取液可由加熱萃取液、置萃取液在減壓下或兩者濃縮。在 較佳之具體實施例中,萃取液經濃縮至其原來體積之約 15 %至約3 0%間。 經濟部中央標準局員工消費合作社印製 配基異黃酮物質自萃取液由加水至萃取液沈澱。在較佳 之具體實施例中,在約6至約8份間之水經加入每份濃縮 萃取液。在添加水至萃取液時,一些配基異黃酮物質經 沈殿。 爲最大化配基異黃酮物質自萃取液之回收,萃取液和水 徹底經混合及然後冷卻。萃取液和水混合在一起一段時 間,較佳地在約3 0分鐘至約1小時間。在較佳之具體實施 例中,萃取液和水在約5 0 °C至約7 5 °C間之溫度下混合,最 佳地約7 0 °C。水和萃取液徹底混合後,混合液經冷卻以 -22- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1241347 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(2〇 ) 沈澱配基異黃_物質。較佳地,萃取液/水混合液經冷至 約5°C至約20°C間,及最佳地至約10°C,一段足以沈殿實 質全部配基異黃酮物質之時間。沈澱之配基異黃_物質然 後可自萃取液/水混合液以傳統方式如由離心或過濾分開。 分開之配基異黃酮物質然後可以水清洗。在較佳之具體 實施例中,配基異黃酮物質以水在約7 Ο X:之溫度下清洗 約5分鐘,其中水清洗液對物質之重量比値爲約〇 8 : j至 約2 : 1間。配基異黃酮物質自清洗液由傳統方法如過滤 或離心分開及乾燥。回收之配基異黃嗣物質典型地含至少 20%5,7,4’ -三巍基異黃酮和至少ι〇%7,4’_二獲基異黃 酮,而物質之剩餘含量係由殘留植物性物質形成,包括其 他配基異黃酮。殘留之植物性物質在配基異黃酮物質係由 黃豆乳漿分離時,爲黃豆物質。 回收之配基異黃酮物質可進一步經純化以產生含至少 4 0 % 5,7,4 ’ ·三#呈基異黃酮和較佳地至少9 〇 〇/〇 5,7,4,_三經 基異黃酮之高5,7,4'·三羥基異黃酮含量物質及含至少 40 %7,4f -二羥基異黃酮之高7,4、二羥基異黃酮含量物 處。配基異黃酮物質可在水性醇溶劑中溶劑溶合。低分子 量醇係較佳地作爲溶劑之醇成份,其中乙醇爲最佳地爲食 品和藥物應用,因爲其低毒性。溶劑之醇含量較佳地在約 3 0%至約90%間,其中約8〇%之醇含量係最佳約的以提 供配基異黃酮物質之良好溶劑溶合。 含落劑落合配基異黃醇物質之水性醇溶液可與吸附物質 接觸一段足以自水性醇溶液分開高5,7,4、三羥基異黃酮 (請先閱讀背面之注意事項再填寫本頁} '訂 瓣 -23-V. Description of the invention (19) Hydroxyl isoflavones, together with residual plant-based substances, are residual soy substances when 5,7,4, and trihydroxy isoflavones are recovered from soybean milk. Recovered &lt; high 7,4 '-dilight isoflavone content material contains at least 40% 7,4, dihydroxyisogonone, which, along with residual plant matter, typically includes a significant amount of methoxy-7 , 4, Erweiji different yellow _. In another specific embodiment of the present invention, the aglycone isoflavone substance is produced from the S-containing aglycone isoflavone extract. As used herein, aglycone isoflavone substances are defined as those containing at least 10% 5,7,4 trihydroxy isoflavones and at least 5% 7,4,2,2-derived isoflavones and other isoflavones and residual plant compounds substance. After the extraction of aglycone isoflavone proteinaceous material, the aglycone isoflavone-rich extract can be concentrated to promote the precipitation of aglycone isoflavone from the extract. The extract can be concentrated by heating the extract, placing the extract under reduced pressure, or both. In a preferred embodiment, the extract is concentrated to between about 15% and about 30% of its original volume. Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs. The aspirin isoflavones are extracted from the extraction solution by adding water to the extraction solution. In a preferred embodiment, between about 6 to about 8 parts of water is added to each concentrated extract. When adding water to the extract, some aglycone isoflavone substances passed through Shen Dian. To maximize the recovery of the isoflavone material from the extract, the extract and water are thoroughly mixed and then cooled. The extract and water are mixed together for a period of time, preferably from about 30 minutes to about 1 hour. In a preferred embodiment, the extract and water are mixed at a temperature between about 50 ° C and about 75 ° C, and most preferably about 70 ° C. After the water and the extraction liquid are thoroughly mixed, the mixed liquid is cooled to -22- This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 1241347 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (20) Ligand isoflavone substance is precipitated. Preferably, the extract / water mixture is cooled to about 5 ° C to about 20 ° C, and most preferably to about 10 ° C, for a period of time that is sufficient for Shen Dian to have all the isoflavone substances. The precipitated isoflavones can then be separated from the extract / water mixture in a conventional manner such as by centrifugation or filtration. The separated aglycone isoflavone material can then be washed with water. In a preferred embodiment, the isoflavone material is washed with water at a temperature of about 70 ° C. for about 5 minutes, wherein the weight ratio of the water cleaning solution to the material is about 0: 8 to about 2: 1 between. The aglycone isoflavone material is separated and dried from the cleaning solution by conventional methods such as filtration or centrifugation. The recovered isoflavone material typically contains at least 20% 5,7,4'-trisyl isoflavones and at least ι0% 7,4'-dimethy isoflavones, and the remaining content of the material is determined by the residual Plant-based substances are formed, including other aglycone isoflavones. Residual plant matter is a soy substance when the aglucone isoflavone substance is separated from the soybean milk. The recovered aglycone isoflavone material may be further purified to produce at least 40% 5,7,4'-tri # isoflavones and preferably at least 900/05, 7, 4, 4 The base isoflavones have a high content of 5,7,4 '· trihydroxy isoflavones and a content of 7,4f-dihydroxy isoflavones with a high content of 7,4 and dihydroxy isoflavones. The ligand isoflavone substance is solvent-soluble in an aqueous alcohol solvent. Low molecular weight alcohols are preferred as the alcohol component of the solvent, with ethanol being the most preferred for food and pharmaceutical applications because of its low toxicity. The alcohol content of the solvent is preferably between about 30% and about 90%, with an alcohol content of about 80% being optimally about to provide good solvent fusion of the isoflavone material. The aqueous alcohol solution containing the falling agent isopropyl alcohol isoflavone substance can be in contact with the adsorbing substance for a period of time sufficient to separate 5, 7, 4, and trihydroxy isoflavones from the aqueous alcohol solution (please read the precautions on the back before filling this page} 'Booklet-23-

1241347 A7 - --'~—__ B7 五、發明説明(21 ) 和呵7,4、二趣基異黃酮含量物質之時間。在較佳之具體 實施例中,鬲5,7,4、三羥基異黃酮和高7,4、二羥基異黃 明各昼物質係自水性醇溶液由逆相H p l c分開。Η P L C管 柱係如前製備,含配基異黃酮物質之水性醇溶液載入管柱 及馬5,7,4'·三輕基異黃酮含量物質和高7,4、二邊基異黃 酮含量物質自管柱以上述之方式溶析。高5,7,4、三羥基 異黃_含量物質含至少4 0%三羥基異黃酮,較佳地至少 9 〇 %三羥基異黃酮,與殘留之植物性物質一起,其在 5.7.4、 三羥基異黃酮係自黃豆乳漿回收時,爲殘留之黃 义物貧。咼7,4’_二經基異黃酮含量物質含至少40%7,4,_ 二巍基異黃g同,與殘留之植物性物質一起。 實驗 本發明係由以下之實施例更詳細説明,使用黃豆乳漿作 爲植物性蛋白質乳漿。實施例意在説明,及不應詮釋以任 何方式限制或者阻礙本發明範疇。 經濟部中央標準局員工消費合作社印製 如上所記,黃豆乳漿包括5,7,4、三羥基異黃酮、7,4、 二羥基異黃酮和6 -甲氧基-7,4、二羥基異黃酮“族,,之異黃 酮’具相對應之糖嘗、共軏物和配基成員,其中5,7,4,_ 三羥基異黃酮族包括共軛物6&quot;-〇Mal 5,7,4,·三輕基異黃 酮糖苷和6〃-0 Ac 5,7,4、三羥基異黃酮糖菩、糖菩 5.7.4、 三羥基異黃酮糖甞和配基5,7,4'-三羥基異黃_ ; 7.4、 二羥基異黃酮族含共軛物6&quot;-01^&amp;17,4、二護基異 黃酮糖甞和6&quot;-OAc 7,4^二羥基異黃酮糖苷、糖:y:7,4、 二羥基異黃酮糖苷和配基7,4^二羥基異黃酮;及6_甲氧 -24- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1241347 A7 B7 五、發明説明(22 ) ^ 基^^—二羥基異黃酮族含共軛物^^撾“一甲氧基 -7,4’-二羥基異黃酮糖甞、糖甞6 -甲氧基_7,4,_二護基異 黃酮糖苷和配基6-甲氧基-7,4'-二羥基異黃酮。在以下表 中,異黃酮之相對濃度係以異黃酮族之百分比測定。例 如,在5,7,4'_三經基異黃晒|族中:〇/〇5,7,4,_三經基異黃 酮糖甞+%6〃-0Mal 5,7,4'_三羥基異黃酮糖嘗+%6,,_ OAc 5,7,4'-三羥基異黃酮糖甞+%5,7,4,_三輕基異黃酮 =1 0 0 %。共軛物轉化成糖甞及糖苷成配芸之程度可由比 較在異黃酮族中各型化合物之百分比決定。 實施例1 在第1個實驗中,異黃酮共軛物轉化成異黃酮糖芬經檢 視。轉化之程度係由異黃酮族之丙二酸酯和乙酸醋之百分 比定量降低偶合著相同異黃酮族之糖答百分比之相對應定 量增加而決定。 經濟部中央標準局員工消費合作社印製 在第1個步驟轉化異黃酮共軛物成異黃酮糖甞中不同 條件之影響係在2個不同溫度下測定。噴霧乾燥之黃豆乳 漿在水中成漿,形成2 %重固形物之黃豆乳漿懸浮液。黃 豆乳漿分爲4個樣品之2組。各組之樣品分別調至p H 6 · 0、7 · 0、9.0和1 1 · 0。樣品組經培養2 4小時,而_組 樣品在4 5 °C下培養及另一組樣品在7 2.5。(:下培養。週基 分析在各樣品上在〇。2、4、6、8和2 4小時下進行,以 測定樣品之異黃酮含量。以下表1説明異黃酮在實驗過程 中之變化和分佈。 -25 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1241347 A7 B7 經濟部中央標準局員工消費合作社印製1241347 A7--'~ -__ B7 V. The description of the invention (21) and the time of 7, 4, and ditriflavone content. In a preferred embodiment, the 5,7,4, trihydroxy isoflavones and the high 7,4, dihydroxy isoflavones are separated from the aqueous alcohol solution by the reverse phase H p lc. Η The PLC column system was prepared as before, and the aqueous alcohol solution containing the ligand isoflavone substance was loaded into the column and the horse's 5,7,4 '· tri-light isoflavone content substance and high 7,4, 2-side isoflavone The content material was eluted from the column in the manner described above. A high 5,7,4, trihydroxy isoflavone content substance contains at least 40% trihydroxy isoflavones, preferably at least 90% trihydroxy isoflavones, together with the remaining plant-derived substances, which are at 5.7.4, When trihydroxy isoflavones are recovered from soy milk, they are deficient in the residual xanthate.咼 7,4’_dijingyl isoflavone content substance contains at least 40% 7,4, _diweiyl isoflavone g, same as the remaining plant-based substances. Experiments The present invention is explained in more detail by the following examples, using soybean milk as a vegetable protein milk. The examples are intended to be illustrative and should not be construed to limit or obstruct the scope of the invention in any way. Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs as mentioned above. Soymilk includes 5,7,4, trihydroxy isoflavones, 7, 4, dihydroxy isoflavones, and 6-methoxy-7,4, dihydroxy groups. Isoflavones ", the isoflavones' have corresponding sugar tastes, conjugates and ligand members, of which the 5,7,4, _ trihydroxy isoflavone family includes the conjugate 6 &quot; -〇Mal 5,7 , 4, · tritrisyl isoflavone glycosides and 6〃-0 Ac 5,7,4, trihydroxy isoflavone glycosides, glycosides 5.7.4, trihydroxy isoflavone glycosides and ligands 5,7,4 ' -Trihydroxy isoflavones; 7.4, Dihydroxy isoflavone family conjugates 6 &quot; -01 ^ &amp; 17,4, diprotection isoflavone glycosides and 6 &quot; -OAc 7,4 ^ dihydroxy isoflavone glycosides , Sugar: y: 7,4, dihydroxy isoflavone glycosides and ligands 7,4 ^ dihydroxy isoflavones; and 6_methoxy-24. This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) ) 1241347 A7 B7 V. Explanation of the invention (22) ^^^-Dihydroxy isoflavone family conjugates ^^ Laos "monomethoxy-7,4'-dihydroxy isoflavone glycocalyx, glycocalyx 6- Methoxy_7,4, _ diamyl isoflavone glycosides and ligand 6-methoxy -7,4'-dihydroxy isoflavone. In the following table, the relative concentrations of isoflavones are determined as a percentage of the isoflavone family. For example, in the 5,7,4'_trijingyl isoflavones | family: 〇 / 〇5,7,4, _trijingyl isoflavone sugar 甞 +% 6〃-0Mal 5,7,4'_ Trihydroxy isoflavone sugar taste +% 6 ,, _ OAc 5,7,4'-trihydroxy isoflavone glycocalyx +% 5,7,4, _trilight isoflavone = 100%. The degree to which the conjugate is converted to glycocalyx and glycoside to formulate a compound can be determined by comparing the percentage of each type of compound in the isoflavone family. Example 1 In the first experiment, the conversion of isoflavone conjugates to isoflavone glycofen was examined. The degree of conversion is determined by a quantitative decrease in the percentage of malonate and acetate acetate of the isoflavone family and a corresponding increase in the corresponding sugar percentage of the same isoflavone family. Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. In the first step, the effects of different conditions in the conversion of isoflavone conjugates to isoflavone glycocalyxes were measured at two different temperatures. The spray-dried soymilk slurry was slurried in water to form a 2% heavy solids soymilk suspension. Soymilk was divided into 2 groups of 4 samples. The samples of each group were adjusted to p H 6 · 0, 7 · 0, 9.0, and 1 1 · 0. The sample group was incubated for 24 hours, while the group sample was incubated at 45 ° C and the other group was at 7 2.5. (: Subculture. Weekly analysis was performed on each sample at 0.2, 4, 6, 8, and 24 hours to determine the isoflavone content of the sample. Table 1 below illustrates the changes and Distribution. -25 This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) 1241347 A7 B7 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1241347 A7 B7 五、發明説明(24 ) e-cm β»甲瓦基 πανϋ. XK4f-三 5J糸三 w条三和 1 XI条 m ΊΑ二 …甲氡基This paper size applies to China National Standard (CNS) A4 (210X297 mm) 1241347 A7 B7 V. Description of the invention (24) e-cm β »Mevacyl πανϋ. XK4f-Three 5J 糸 Three Articles Three and 1 XI Articles m ΊΑ 二 ... formyl

, 超基異裡基真 基異黃 三沒基基異竟基異黃基異黃段基異基異黃-7,冬二-7本二^ 樣品专胡_甞明檐甞:異黃網职嫌甞《I甞 S^l# 黄胡职擔甞異★胡被甞基異黃W 頁分比' (請先閲讀背面之注意事項再填寫本頁) 卢 t 711*C t-0 16 6S 0 19 15 65 2 18 32 33 36 t-2小時 33 41 0 19 33 48 2 17 39 27 34 小時 43 39 0 17 42 39 2 17 A6 2! 33 i-H、時 51 33 0 17 49 32 3 17 50 19 31 小時 Η 21 0 16 54 27 3 16 57 14 29 小時 ao 5 0 15 77 5 3 16 66 0 34 '訂 t-0 16 65 0 19 15 65 2 18 32 32 30 |**2小時 50 X 0 16 50 ^4 0 15 50 20 30 Μ小時 57 27 0 15 57 27 0 16 A9 17 34 t-6小時 62 23 0 15 62 23 0 IS 54 13 34 卜》小時 67 19 0 !4 67 11 0 15 57 10 34 卜24小時 70 !7 0 13 63 17 0 20 50 10 39 t-0 16 65 0 19 13 65 2 18 32 33 36 r-2小時 15 0 0 15 η 0 0 It 62 0 3t t—小4 囂5 0 0 15 SI 0 0 19 63 0 37 t-«小時 16 0 0 Μ 79 0 0 21 61 0 39 t-l小時 t7 0 0 13 77 0 0 23 60 0 40 t-24小時 90 0 0 10 53 0 0 47 46 0 54 pH 7 η 1-0 16 65 0 19 15 65 2 II 32 33 36 *•2小時 41 43 0 17 41 39 2 17 47 25 29 小時 52 • 32 0 1$ 50 32 2 16 49 IS 33 小時 5t 27 0 IS 56 26 2 16 3. 13 35 卜8小4 64 21 0 IS H 20 2 16 55 12 32 1-24 小“ 59 4 0 31 61 3 0 36 50 0 50 -27- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 經濟部中央標準局員工消費合作社印製 mLmx 1-0 16 65 0 19 15 65 2 It 32 33 36 Ι·2小時 13 4 0 13 12 4 0 14 64 0 36 H小時 II 2 0 1! Μ 2 0 13 65 0 35 *·Μ、時 90 0 0 10 IS 0 0 15 65 0 33 卜1小時- 91 0 0 9 麻5 0 0 IS 65 0 35 *24 小 4 100 0 0 0 IS 0 0 13 tuo 0 0 1241347 A7 B7 五、發明説明(25) 5,7,4-二 5,7,冬二 5,7,年-二超 5,7,4· 7,4-^¾ 7,-^0-¾ 74r~ji. -74f^zJ»' 6-^5 A /c m» λ 达口 超i異-▲異黃二沒基‘異气‘異黃&amp;異:黃/Ϊ基異基異黃丄-7,·^·二1¾^ -7术二^ 00黃9^|# X明ϋ#明檐Ϋ :異黃W 明嫌贫明檐甘酌喊隹黃胡蜗味^:異’黄稱嫌贫^異 頁分比, t-2小時 86 r»4小時 87 t»6小時 Π t-β小時 88 t-24小時 78 65 0 0 0 0 0 19 14 13 13 12 22 76 72 67 65 0 0 0 0 0 24 28 33 39 76 32 57 54 48 33 0 0 0 0 0 36 43 46 49 52 經濟部中央標準局員工消費合作社印製 如由6 &quot; - Ο M al和6 &quot; - 0 A c異黃酮共軛物化合物之相對濃 度降低及糖苷5,7,4、三羥基異黃酮糖甞、7,4f -二羥基異 黃酮糖铝和6 -甲氧基7,V -二羥基異黃酮糖甞之相對應濃 度增加所示,第1個轉化步驟是在更高、更驗性ρ Η條件和 更高溫度下最快速和完全。實質完全轉化異黃酮共軛物成 異黃酮糖茹發生在pH 9和1 1樣品在45 °C和72.5 °C兩者 下。轉化亦在pH6和7樣品在72.5°C下進行至近乎完全。 實施例2 在第2個實驗中,轉化異黃酮糖甞成配基異黃酮經檢 視。由第1個轉化步驟產生之富含異黃酮糖棼之乳漿經用 以檢視第2個轉化步驟。轉化之程度由異黃酮族之糖苷百 分比之定量降低偶合著相同異黃酮族之配基百分比之相對 應定量增加測定。 黃豆乳漿經轉化成富含異黃酮糖苷之乳漿,由調整乳漿 之p Η至1 1.0及在3 5 °C下培養3 0分鐘。1個富含糖茹之乳 漿樣品在4 5 °C下培養2 4小時,以測定異黃酮糖芬轉化成 配基異黃酮,由乳漿中殘留之酵素。其他富含糖茹之乳漿 -28 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) —Ini#! (請先閱讀背面之注意事項再填寫本頁) 訂 1241347 A7 B7 五、發明説明(26 樣品以下列商業來源之補充酵素接種:生物果膠酶 100L、生物果膠酶300L、生物果膠酶〇K70L、乳糖酶 F、α-Gal 600L、G-Zyme G990、探索生物乳糖酶 3 0,000 &gt; Novo Lactozyme 3 000L &gt; Maxilact L2000 E n z e c 〇眞菌乳糖酶、P f i z e r中性乳糖酶和探索中性乳糖 酶。以 oc-Gal 600L、G-Zyme G990、生物果膠酶 100L、生物果膠酶300L、生物果膠酶OK70L、乳糖酶ρ 和Enzeco眞菌乳糖酶接種之樣品在接種前pH調至pH 4.5 。以 Novo Lactozyme 3 000L 、 Maxilact L2000、Pfizer中性乳糖酶、探索生物乳糖酶3〇,〇〇〇和 探索中性乳糖酶接種之樣品,在接種前p Η調至4.5和7.0 之pH。補充酵素樣品然後在5 〇。(:下培養,除了乳糖酶F 樣品,其在35 °C下培養及生物果膠酶300L和生物果膠酶 OK70L樣品’其在4〇°C下培養。以樣品在時段後取出及 測定異黃酮含量。以下表2顯示在實驗過程中異黃_之 分佈。 (請先閱讀背面之注意事項再填寫本頁) *訂——Γ. 經濟部中央標準局員工消費合作社印製 -J— · I =- - I ϋ— -29 参紙張尺度適财_家標準(CNS ) A4規格G χ 297公# ) 1241347 Α7Β7 五、發明説明( 27 表 2 e-om 邳-冰 ία’-二 6*甲氣基 η &amp;甲ιι基 &amp;甲氣基 頁分比. 殘#酵素:〇Η90. t-0 86 t-2小時 89 卜4小b 92 t»6小時 W 1·24小時0 9 9 S 7 100 79 SI 82 12 Ο 18 U IS IS 100 100 100 100 100ο Ο Ο Ο Ο 100 生物 jMfg»3QCL|JM5 5CTC QIAIOO克富含糖替之IL漿 1-0 74 〇 t-0.5小時 46 〇 t-1 小生· 22 〇 ι-1.5ψϋ II 〇 1*2.,ί、碍 6 〇 11 0οοο IS 54 71 89 94 100 Α6 24 Μ 7 Ο 51 73 52 90 77 75 66 73 70 Ο Ο 10 Ο Ο 23 25 24 27 30, Super-based iso-rich base, real-based base, iso-based base, iso-based base, iso-based base, iso-based base, iso-based base, iso-based base, iso-based base, iso-based base, iso-based base, etc. -7甞 《I 甞 S ^ l # Huang Hu's job title is different ★ Hu quilt base is different from W page fraction '(Please read the precautions on the back before filling this page) Lu t 711 * C t-0 16 6S 0 19 15 65 2 18 32 33 36 t-2 hours 33 41 0 19 33 48 2 17 39 27 34 hours 43 39 0 17 42 39 2 17 A6 2! 33 iH, hours 51 33 0 17 49 32 3 17 50 19 31 Hours Η 21 0 16 54 27 3 16 57 14 29 hours ao 5 0 15 77 5 3 16 66 0 34 'order t-0 16 65 0 19 15 65 2 18 32 32 30 ** 2 hours 50 X 0 16 50 ^ 4 0 15 50 20 30 μh 57 27 0 15 57 27 0 16 A9 17 34 t-6 hours 62 23 0 15 62 23 0 IS 54 13 34 hours 67 19 0! 4 67 11 0 15 57 10 34 24 hours 70! 7 0 13 63 17 0 20 50 10 39 t-0 16 65 0 19 13 65 2 18 32 33 36 r-2 hours 15 0 0 15 η 0 0 It 62 0 3t t—small 4 0 0 15 SI 0 0 19 63 0 37 t- «hour 16 0 0 Μ 79 0 0 21 61 0 39 tl hour t7 0 0 13 77 0 0 23 60 0 40 t-24 hours 90 0 0 10 53 0 0 47 46 0 54 pH 7 η 1-0 16 65 0 19 15 65 2 II 32 33 36 * • 2 hours 41 43 0 17 41 39 2 17 47 25 29 hours 52 • 32 0 1 $ 50 32 2 16 49 IS 33 hours 5t 27 0 IS 56 26 2 16 3. 13 35 Bu 8 small 4 64 21 0 IS H 20 2 16 55 12 32 1-24 small "59 4 0 31 61 3 0 36 50 0 50 -27- This paper size applies to Chinese national standards (CNS) Α4 specification (210 × 297 mm) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs mLmx 1-0 16 65 0 19 15 65 2 It 32 33 36 1.2 hours 13 4 0 13 12 4 0 14 64 0 36 H hours II 2 0 1! Μ 2 0 13 65 0 35 * · M, hours 90 0 0 10 IS 0 0 15 65 0 33 1 hour-91 0 0 9 hemp 5 0 0 IS 65 0 35 * 24 small 4 100 0 0 0 IS 0 0 13 tuo 0 0 1241347 A7 B7 V. Description of the invention (25) 5,7,4-two 5,7, winter two 5,7, year-two super 5,7,4 · 7, 4- ^ ¾ 7,-^ 0-¾ 74r ~ ji. -74f ^ zJ »'6- ^ 5 A / cm» λ Dakou Super i-Iso- ▲ Iso-huang dimedi' Iso-qi 'Iso- yellow & Different: Huang / ΪBased Isoisocyanate-7 , · ^ · 二 1¾ ^ -7 Surgery 2 ^ 00 黄 9 ^ | # X 明 Ϋ # 明 阴 Ϋ: 异 黄 W Ming Shao Ming Yan隹 Huang Hu Snail ^: Yi 'Huang said to be poor ^ Different page fraction, t-2 hours 8 6 r »4 hours 87 t» 6 hours Π t-β hours 88 t-24 hours 78 65 0 0 0 0 19 14 13 13 12 22 76 72 67 65 0 0 0 0 24 28 33 39 76 32 57 54 48 33 0 0 0 0 0 36 43 46 49 52 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs as described by 6 &quot;-〇 M al and 6 &quot;-0 A c The relative concentration of isoflavone conjugate compounds is reduced and The corresponding increase in the glycosides 5,7,4, trihydroxy isoflavone glycocalyx, 7,4f-dihydroxy isoflavone saccharide and 6-methoxy 7, V-dihydroxy isoflavone glycoside are shown in the first This transformation step is the fastest and most complete at higher, more experimental ρΗ conditions and higher temperatures. Substantially complete conversion of the isoflavone conjugate into isoflavone sugars occurs at pH 9 and 11 samples at both 45 ° C and 72.5 ° C. Conversions were also performed to near complete at pH 6 and 7 samples at 72.5 ° C. Example 2 In a second experiment, the isoflavone glycosides were converted into aglycone isoflavones and examined. The isoflavone saccharin rich milk produced from the first transformation step was used to examine the second transformation step. The degree of conversion is determined by the quantitative decrease of the percentage of glycosides of the isoflavone family, and the corresponding quantitative increase of the percentage of ligands coupled to the same isoflavone family. Soybean milk is transformed into isoflavone glycoside-rich milk. The pH of the milk is adjusted to 1 1.0 and incubated at 35 ° C for 30 minutes. A sugar-rich milk sample was cultured at 45 ° C for 24 hours to determine the isoflavone glycofen that was converted to aglycone isoflavones and the enzymes remaining in the milk. Other syrup rich in sugar Ru-28 This paper size applies to Chinese National Standard (CNS) A4 specification (210X 297 mm) —Ini #! (Please read the notes on the back before filling this page) Order 1241347 A7 B7 5 2. Description of the invention (26 samples were inoculated with supplemental enzymes from the following commercial sources: biological pectinase 100L, biological pectinase 300L, biological pectinase 0K70L, lactase F, α-Gal 600L, G-Zyme G990, exploring organisms Lactase 3 0,000 &gt; Novo Lactozyme 3 000L &gt; Maxilact L2000 E nzec 〇 lactase, P fizer neutral lactase and explore neutral lactase. With oc-Gal 600L, G-Zyme G990, bio pectinase 100L, biological pectinase 300L, biological pectinase OK70L, lactase ρ and Enzeco bacterial lactase inoculated samples pH adjusted to pH 4.5 before inoculation. Novo Lactozyme 3 000L, Maxilact L2000, Pfizer neutral lactase, Explore biological lactase 30,000 and neutral lactase inoculated samples, adjust pH to pH 4.5 and 7.0 before inoculation. Supplementary enzyme samples are then cultured at 50% (except lactase F Sample at 35 ° C Samples of nutrient and biological pectinase 300L and biological pectinase OK70L were cultured at 40 ° C. The samples were taken out after a period of time and the isoflavone content was measured. The following Table 2 shows the distribution of isoflavones during the experiment. (Please read the notes on the back before filling this page) * Order——Γ. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs -J— · I =--I ϋ— -29 (CNS) A4 specification G χ 297 Male #) 1241347 Α7Β7 V. Description of the invention (27 Table 2 e-om 冰-冰 ία'- 二 6 * methylamino group &amp; methyl group &amp; methyl group page fraction残 # 酶: 〇Η90. T-0 86 t-2 hours 89 44 small b 92 t »6 hours W 1.24 hours 0 9 9 S 7 100 79 SI 82 12 Ο 18 U IS IS 100 100 100 100 100ο Ο Ο Ο Ο 100 biological jMfg »3QCL | JM5 5CTC QIAIOO grams of sugar-rich IL pulp 1-0 74 〇t-0.5 hours 46 〇t-1 Xiaosheng · 22 〇-1.5ψϋ II 〇1 * 2. , Ί, hinder 6 〇11 0οοο IS 54 71 89 94 100 Α6 24 Μ 7 Ο 51 73 52 90 77 75 66 73 70 Ο Ο 10 Ο Ο 23 25 24 27 30

Id—(請先閲讀背面之注意事項再填寫本頁) •pLi- HB1·· —ten -訂 罇 經濟部中央標準局員工消費合作社印裝 -30- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1241347 A7 B7 ^jm, 五、發明説明(28) (^-ΟΜί, 6&gt; 甲氣基 e〇Mii 5,7,4'-三 5,7半三 5,7,&amp;三輕 7+1 7少-二1¾ 7,々-二^ 7,4'-二-7,4'·^$’ 6·甲 II基 6» 甲氣基 ^ 搜基異超基炎基異黃 三沒基基基異黃基異黃超基異基異黃-7,本二^ -7·4Ί 樣品黄g甞黃明*|甞晒檐甞:異黄胡 明嫌甞明搶智:黃嗣 嫌站異奇胡嫌甞基異黃明 頁分比' 生物早释雖OKTOL rf!4 &lt; 4&lt;rg (Η_克富含核贫之^费 Η) 74 0 11 15 100 0 0 0 77 0 23 HJ.5小時 69 0 0 31 70 0 0 30 76 0 24 卜1小時 54 0 0 46 53 3 0 44 76 10 24 Μ.5!小時 AA 0 0 56 43 0 4 52 75 0 23 t*2小祷 37 0 0 63 35 3 0 62 74 0 26Id— (Please read the notes on the back before filling in this page) • pLi- HB1 ·· —ten-Bookmarked by the Consumers' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs-30- This paper size applies to China National Standard (CNS) A4 Specifications (210X297 mm) 1241347 A7 B7 ^ jm, V. Description of the invention (28) (^ -ΟΜί, 6 &gt; Methanyl e〇Mii 5,7,4'-three 5,7 half-three 5,7, &amp; Sanqing 7 + 1 7 Shao-two 1¾ 7, 々-two ^ 7,4'-di-7,4 '· ^ $' 6 · methyl II group 6 »methylamino group ^ search base isomeryl radical Isoflavoryl, isomeryl, isoflavyl, isoflavogenous, isobyl, isoflavage-7, Benji ^ -7 · 4Ί Sample yellow g 甞 甞 明 * | 甞 Sun eaves 甞: Isomerized yellow Hu Ming 甞 甞 明 甞: Huang 嗣 嗣 站Bizarre suspicion that the base is different from the yellow page, although the biological early release is OKTOL rf! 4 &lt; 4 &lt; rg (Η_gram rich in nuclear poverty ^ feeΗ) 74 0 11 15 100 0 0 0 77 0 23 HJ. 5 hours 69 0 0 31 70 0 0 30 76 0 24 1 hour 54 0 0 46 53 3 0 44 76 10 24 M.5! Hours AA 0 0 56 43 0 4 52 75 0 23 t * 2 37 0 0 63 35 3 0 62 74 0 26

生物 咖 LpH45 4Q°C 〇14如00克富絲漿 1-0 50 2 0 47 61 2 0 37 60 0 40 t-Ι小時 25 2 0 73 31 2 0 67 54 0 55 t-2小時 12 2 0 t6 15 1 0 S3 51 0 50 1-3!小時 7 2 0 92 9 1 0 90 0 0 100 qi克αοο克富含糖答之乳漿 ϋ —ϋ ϋ (請先閲讀背面之注意事項再填寫本頁) t-0 47 I 0 45 45 7 0 4t 74 0 26 Ι·0.5小時 9 9 0 η S 9 0 S3 55 0 39 Μ小碎 3 S 0 19 2 t 0 90 46 0 Μ 卜2小時 0 9 0 91 0 t 0 92 32 0 (Λ 5Ϊ石100克富嫌似L漿 H) S3 〇 t-l小時 4 0 卜2小4 1 〇 卜3小诗 0 〇 m克αοο克1 H) 13 H).5小時 17 卜1;小時 6 卜2小4 〇 17 S3 0 0 17 SO 96 2 0 0 91 23 99 0 0 0 100 10 100 0 0 0 100 1 16 79 3 1 17 15 η 16 4 3 77 39 93 5 4 3 17 26 99 0 4 3 92 4 20 77 76 7f 15 55 '訂 瓣. 經濟部中央標準局員工消費合作社印製 n-y〇9w pH 4 &lt; «rc Q1克/100克富含嫌洛^之乳漿 Η) S3 0 0 17 S3 0 0 17 to 0 20 1-1小時 49 1 0 31 41 0 0 59 t2 0 IS 卜2小時 30 1 0 69 21 0 0 79 79 0 21 1-3小時 II 0 0 12 11 0 0 t9 69 11 19 -31 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 1241347 A7 B7 五、發明説明(29 5,7,4'-三 5,7,冬主 5,7,冬三輕 5,7,4,- , 瘦基異裡基炎基異黃 三瘦基 樣品黃黄明_甞晒嫌甞:異黄辆 7,4Ί 7,4Ί 〜甲氣基 -7,。甲6&gt;甲氣基 基異黃基異黃基異黃瘦基異基異黃-7,木二-7本二S «^甞s^rs:南明 異黄胡嫌甞基異黄胡頁分比、 yetitJjflBi Q2^g〇Q,Bio coffee LpH45 4Q ° C 〇14 such as 00 grams of rich silk pulp 1-0 50 2 0 47 61 2 0 37 60 0 40 t-1 hours 25 2 0 73 31 2 0 67 54 0 55 t-2 hours 12 2 0 t6 15 1 0 S3 51 0 50 1-3! hours 7 2 0 92 9 1 0 90 0 0 100 qi grams αοο grams of sugar-rich milk ϋ —ϋ ϋ (Please read the notes on the back before filling in this (Page) t-0 47 I 0 45 45 7 0 4t 74 0 26 Ι · 0.5 hours 9 9 0 η S 9 0 S3 55 0 39 Μ small broken 3 S 0 19 2 t 0 90 46 0 Μ 2 hours 0 9 0 91 0 t 0 92 32 0 (Λ 5 vermiculite 100 g is rich like L slurry H) S3 〇tl hours 4 0 bu 2 small 4 1 〇 3 small poem 0 〇m g αοοg 1 H) 13 H). 5 hours 17 bu 1; hours 6 bu 2 small 4 〇17 S3 0 0 17 SO 96 2 0 0 91 23 99 0 0 0 100 10 100 0 0 0 100 1 16 79 3 1 17 15 η 16 4 3 77 39 93 5 4 3 17 26 99 0 4 3 92 4 20 77 76 7f 15 55 'Booklet. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs ny〇9w pH 4 &lt; «rc Q1g / 100g is rich in scent ^ S3 0 0 17 S3 0 0 17 to 0 20 1-1 hours 49 1 0 31 41 0 0 59 t2 0 IS 2 hours 30 1 0 69 21 0 0 79 79 0 21 1-3 hours II 0 0 12 11 0 0 t9 69 11 19 -31 This paper size applies Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1241347 A7 B7 V. Description of the invention (29 5,7,4'-three 5,7, Dongzhu 5,7 , Dongsanqing 5,7,4,-, Leptyl isoryl, inflammatory base, isoflavone, triseptyl sample, Huang Huangming, 甞 甞 甞 甞 甞: Isocyanine 7, 4, Ί 7, 4 Ί ~ methylamino -7, ... 6 &gt; Methyl isoflavyl isoflavyl isoflavyl isoflavone isotyl isoflavone-7, wood Ⅱ-7 this two s Q2 ^ g〇Q,

JMCE 丨克富含糖接之乳漿 經濟部中央標準局員工消費合作社印製JMCE 丨 Glycol-rich milk paste Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

liULi Η) 7麗 7 0 15 77 7 0 16 75 6 19 卜1小時 71 f 0 M 10 7 0 13 0 14 t-4小時 77 t 0 15 to 7 0 &quot; M 0 16 iHTft t-0 71 7 0 15 n 7 0 16 75 6 19 t-ι小時 η 塞 0 20 77 7 0 16 72 0 2t tM小4 61 1 0 24 74 7 0 19 61 0 39 Um;I^ V -ww » vrr 02獅克富練#漿 liLU t-0 7囂 7 0 15 77 7 0 16 75 6 IV t-1小時 71 7 0 13 n 7 0 16 75 6 19 l*-4小時 76 7 0 17 76 7 0 !7 73 6 21 nH7tt H) 71 7 0 15 77 7 0 16 75 6 19 t-1小時 71 7 0 22 73 6 0 21 5« 7 31 卜4小時 65 7 0 21 69 5 0 26 32 0 AM ffisr中性乳_^r 〇2克加0克富含糖芬ϋ漿 •ULii t-0 7S 7 0 IS 77 7 0 16 75 6 19 l-p小時 77 7 0 16 77 6 0 17 73 7 20 M小蛉 77 0 7 16 77 6 0 17 76 0 24 Η 70 Η) 71 7 0 15 77 7 0 16 75 6 19 1-1小時 70 7 0 23 72 5 0 23 70 6 24 小時 55 7 0 3t 60 6 0 34 66 0 W -32- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1^1- n^i *» -— - ϋϋ · 1^1 I(請先閱讀背面之注意事項再填寫本頁) 『訂 _ A7 1241347 B7 五、發明説明(30 ) ^ava, W·三 5,7,冬主 ^•OAq 三輕 5Z冬 7^4 k 6»甲氣基 6·甲n基. 6·甲#1基 樣品黑&amp; 基異普 三躲 :異糊 鏘鏘IK歡 基異舟 鋪甞 異黄明H站基異黄《 、百分比 探索生物#以1醜30J〇0050°C Q2j?/100克富練漿 r«LU t-0 71 7 0 15 77 7 0 16 75 6 19 1-1小時 0 6 0 94 0 6 0 94 0 0 100 M小時 0 4 0 96 0 5 0 95 0 0 100 Μ) 71 7 0 15 77 7 0 16 75 6 f9 t*l小時 2 7 0 91 3 7 0 90 29 0 71 卜4小時 0 7 0 93 0 6 0 94 0 0 100 探索生物,隱50eC 〇2ίΑ〇〇ίϊ 含^答^漿 H3JLX Η) 78 7 0 15 77 7 0 16 75 6 19 t-卜】、時 73 6 0 21 76 5 0 19 79 0 21 Μ小碎 73 6 0 21 76 5 0 19 76 0 24 atLlfl t-0 71 7 0 15 77 7 0 16 75 6 19 卜1小時 2 7 0 91 7 4 0 19 15 0 15 Μ小時 0 7 0 93 0 4 0 96 0 0 100 如由分別轉化5,7,4 f - 三羥基異黃酮糖嘗 、7,4,_二 羥基 異黃酮糖嘗和6- 甲氧 基-7,4、 -二 羥基 異黃 酮糖 ^成 (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 5,7,4\三羥基異黃酮、7,4\二羥基異黃酮和6-甲氧基-7,V -二經基異黃酮所示,實質完全轉化異黃酮糖嘗成配 基異黃酮經達成。補充酵素顯著增加轉化率’而一些補充 酵素在1小時内完成實質完全轉化。在p Η 4 · 5下發現最有 效之補充酵素爲生物果膠酶1 〇 〇 L、生物果膠酶3 0 0 L、乳 糖酶F、α-Gal 600L、G-Zyme G990、探索生物乳糖 酶30,000和Enzeco眞菌乳糖酶。在pH 7.0下發現最有 _-33- 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 1241347 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(31 ) 效之補充酵素爲探索生物乳糖酶3〇,〇〇〇和探索中性乳糖酶。 實施例3 在另1個實驗中,配基異黃酮乳漿蛋白質物質係自富含 配基異黃酮之黃豆乳漿回收。第1個富含配基異黃酮之黃 豆乳漿樣品重1 000克,含30毫克5,7,4,_三羥基異黃酮、 37毫克7,4、二羥基異黃酮和7毫克6_甲氧基_7,4,_二輕 基異黃_,係由在低熱下蒸發至〗63克濃縮(濃縮比値 -1 : 6 · 1 )。濃縮之乳漿經熱至凝結在乳漿中之蛋白質物 質,及經離心以進一步濃縮乳漿蛋白質物質。含2 5毫克 5,7,4’ -三羥基異黃酮、32毫克7,4f -二羥基異黃酮和6毫 克6 -甲氧基-7,4’ -二羥基異黃酮之21克乳漿蛋白質物質 係自乳漿分開。回收之乳漿蛋白質物質含在合併乳漿和乳 漿蛋白質物質中82%5,7,4'_三羥基異黃酮、88%7,4'-二 超基異黃酮和77 %6-甲氧基·7,4、二羥基異黃酮。 第2個富含配基異黃酮之黃豆乳漿樣品重4〇〇克及含12 毫克5,7,4、三羥基異黃酮、15毫克7,4、二羥基異黃酮 和3耄克6 -甲氧基-7,4 ’ -二經基異黃酮經熱至凝結在乳漿 中之蛋白質物質’而不濃縮乳漿。凝結之乳漿蛋白質物質 和乳漿經離心以進一步濃縮乳漿蛋白質物質。8 7克乳漿 蛋白質物質經回收,含5毫克5,7,4、三羥基異黃酮、7亳 克7,4、二經基異黃酮和1毫克6 -甲氧基二藉基異黃 酮。回收之乳漿蛋白質物質含在合併乳漿蛋白質物質和乳 製中44%5,7,4'_三經基異黃酮、47%7,4,-二羥基異黃酮 和3 4%6-甲氧基-7,4'二羥基異黃酮。 -34 本紙張尺度適用中國國定德進(CNS ) Α4规格(輅、 - (請先閱讀背面之注意事項再填寫本頁)liULi Η) 7 Li 7 0 15 77 7 0 16 75 6 19 1 hour 71 f 0 M 10 7 0 13 0 14 t-4 hours 77 t 0 15 to 7 0 &quot; M 0 16 iHTft t-0 71 7 0 15 n 7 0 16 75 6 19 t-ι hours η plug 0 20 77 7 0 16 72 0 2t tM small 4 61 1 0 24 74 7 0 19 61 0 39 Um; I ^ V -ww »vrr 02富 练 # 浆 liLU t-0 7 7 7 15 15 7 7 0 16 75 6 IV t-1 hours 71 7 0 13 n 7 0 16 75 6 19 l * -4 hours 76 7 0 17 76 7 0! 7 73 6 21 nH7tt H) 71 7 0 15 77 7 0 16 75 6 19 t-1 hour 71 7 0 22 73 6 0 21 5 «7 31 bu 4 hours 65 7 0 21 69 5 0 26 32 0 AM ffisr neutral milk _ ^ r 〇2 grams plus 0 grams of sugar-rich syrup • ULii t-0 7S 7 0 IS 77 7 0 16 75 6 19 lp hours 77 7 0 16 77 6 0 17 73 7 20 M small 蛉 77 0 7 16 77 6 0 17 76 0 24 Η 70 Η) 71 7 0 15 77 7 0 16 75 6 19 1-1 hours 70 7 0 23 72 5 0 23 70 6 24 hours 55 7 0 3t 60 6 0 34 66 0 W -32- This paper size is in accordance with Chinese National Standard (CNS) A4 (210X297mm) 1 ^ 1- n ^ i * »-—-ϋϋ · 1 ^ 1 I (Please read the precautions on the back before filling this page ) "Order_ A7 1241347 B7 V. Description of the invention (30) ^ ava, W · 3 5,7, winter master ^ • OAq Sanqing 5Z winter 7 ^ 4 k 6» A gas group 6. A n group. 6 · A # 1 基 样 黑 &amp; kiyipu three hides: yihuan IK Huanji Yizhoupuyi yihuangming H station base yihuang 《、 Percentage exploration creature ## 1ug 30J0050 ° C Q2j? / 100 Kefu training pulp «LU t-0 71 7 0 15 77 7 0 16 75 6 19 1-1 hours 0 6 0 94 0 6 0 94 0 0 100 M hours 0 4 0 96 0 5 0 95 0 0 100 Μ ) 71 7 0 15 77 7 0 16 75 6 f9 t * l hours 2 7 0 91 3 7 0 90 29 0 71 4 hours 0 7 0 93 0 6 0 94 0 0 100 Explore creatures, hidden 50eC 〇2ίΑ〇〇 ίϊ Contains H3JLX Η) 78 7 0 15 77 7 0 16 75 6 19 t-bu], hour 73 6 0 21 76 5 0 19 79 0 21 Μ small broken 73 6 0 21 76 5 0 19 76 0 24 atLlfl t-0 71 7 0 15 77 7 0 16 75 6 19 1 hour 2 7 0 91 7 4 0 19 15 0 15 μh 0 7 0 93 0 4 0 96 0 0 100 If converted by 5, 7, respectively , 4 f -trihydroxy isoflavone sugar taste, 7,4, _dihydroxy isoflavone sugar taste and 6-methoxy-7,4, -dihydroxy isoflavone sugar ^ cheng (please read first (Please read the notes on the reverse side and fill in this page again) Print the 5,7,4 \ trihydroxy isoflavones, 7,4 \ dihydroxy isoflavones and 6-methoxy-7, V printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs -As shown by the diacid isoflavones, substantially complete conversion of the isoflavone sugars to the aglucone isoflavones was achieved. Supplemental enzymes significantly increase the conversion rate ’and some supplementary enzymes complete substantially complete conversion within 1 hour. The most effective supplemental enzymes found at pΗ4.5 are biopectinase 1000L, biopectinase 3 00L, lactase F, α-Gal 600L, G-Zyme G990, and exploration of biological lactase 30,000 and Enzeco P. lactase. Found at pH 7.0_-33- This paper size applies to Chinese National Standard (CNS) A4 (210 X 297 mm) 1241347 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (31) The effective supplement enzymes are exploring biological lactase 30,000 and neutral lactase. Example 3 In another experiment, the aglycone isoflavone milk protein material was recovered from a soybean milk rich in aglycone isoflavones. The first soymilk sample rich in aglycone isoflavones weighed 1,000 grams and contained 30 mg of 5,7,4, _trihydroxy isoflavone, 37 mg of 7,4, dihydroxy isoflavone, and 7 mg of 6-methyl The oxy_7,4, _dilightyl isoflavone is evaporated from low heat to 63 grams of concentrated (concentration ratio 値 -1: 6 · 1). The concentrated milk is heated to the proteinaceous matter coagulated in the milky slurry and centrifuged to further concentrate the milky proteinaceous matter. 21 grams of serum protein containing 25 mg of 5,7,4'-trihydroxy isoflavones, 32 mg of 7,4f-dihydroxy isoflavones and 6 mg of 6-methoxy-7,4'-dihydroxy isoflavones The substance is separated from the milk. Recovered milk protein material contains 82% 5,7,4'_trihydroxy isoflavones, 88% 7,4'-disuperyl isoflavones and 77% 6-methoxyl in the combined milk and milk protein materials Radicals 7,4, dihydroxy isoflavones. The second soymilk sample rich in aglycone isoflavones weighed 400 grams and contained 12 mg of 5,7,4, trihydroxy isoflavones, 15 mg of 7,4, dihydroxy isoflavones, and 3 g of 6- Methoxy-7,4'-diazonyl isoflavones are heated to the proteinaceous material that coagulates in the milk 'without concentrating the milk. The coagulated milk protein material and the milk are centrifuged to further concentrate the milk protein material. 8 7 grams of milk protein material was recovered and contained 5 mg of 5,7,4, trihydroxy isoflavones, 7 g of 7,4, diacryl isoflavones, and 1 mg of 6-methoxydiboryl isoflavones. Recovered milk protein material contained 44% 5,7,4'_trisyl isoflavone, 47% 7,4, -dihydroxy isoflavone and 34% 6-methyl in the combined milk protein material and milk Oxy-7,4 'dihydroxy isoflavone. -34 This paper size is applicable to China National Dejin (CNS) Α4 specifications (辂,-(Please read the precautions on the back before filling this page)

1T J-- 1241347 A7 —------- B7 五、發明説明(32 ) &gt;比較罘1和2個樣品之乳漿蛋白質物質,清楚地在分開 乳漿蛋白質物質前濃縮富含配基異黃嗣之乳聚造成在乳裝 蛋白貝物資中配基異黃酮之增加捕獲。 實施例4 在另1個實驗中,配基異黃酮物質經回收,由水性醇萃 取液萃取配基異黃酮乳漿蛋白質物質及自萃取液沈殿配基 異黃酮物質。 821克配基異黃酮乳漿蛋白質物質含86%乾重蛋白質、 4.7克5,7,4'_三羥基異黃酮、22克7,4、二羥基異黃酮 經濟部中央標準局員工消費合作社印裝 和0.36克6 -甲氧基_7,4、二羥基異黃酮係由轉換在乳漿 中異育酮共輛物和異黃酮糖甞成配基異黃酮及自乳漿回收 配基異黃酮乳漿蛋白質物質而提供。配基異黃酮乳漿蛋白 兔物負以6360克80 : 20重量%乙醇/水溶液(77 : j溶液 /配基異黃酮乳漿蛋白質物質)在6 〇 I下萃取4 5分鐘。萃 取後’生成桌經冷至25 C及在眞空下在Whatman 4號濾、 紙上過濾。濕餅重1584克,含798克固形物,〇.8克 5,7,4'-三羥基異黃酮、〇·4克7,4、二羥基異黃酮和〇.02 克6 -甲氧基-7,4、二護基異黃酮經回收,及與3397克澄 清萃取液一起,含23克固形物,3.9克5,7,4 \三邊基異 黃酮、1.8克7,4,_二羥基異黃酮和〇·34克6-甲氧基 -7,4、二羥基異黃酮。 濾餅第2次以2 0 0 0克8 0 : 2 0重量%乙醇/水溶液(2 3 : 1溶液/最初配基異黃酮乳漿蛋白質物質)在2 5 °C下萃取5 分鐘。第2次萃取後,生成之漿再在Whatman第4號濾紙 -35- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ' &quot; 1241347 A7 B7 五、發明説明(33 ) 上過濾。濕餅重1542克及含794克固形物、0·3克 5,7,4’ -三經基異黃酮、0.1克7,4'-二衆基異黃酮和0·01 克6 -甲氧基-7,4、二羥基異黃酮與第2次萃取液一起回 收,重2042克,含4.0克固形物、0.5克5,7,4'_三羥基異 黃酮、0.3克7,4、二羥基異黃酮和〇.〇1克6 -甲氧基-7,4、二每基異黃_。萃取液經合併及含在配基異黃I同乳 漿蛋白質物質中最初之94%5,7,4,-三羥基異黃酮和 9 5%7,4'-二羥基異黃酮。 萃取液然後由蒸發在Buchi蒸發器中在眞空下在70 C 下濃縮至1 5 2 8克(2 0 %原來合併之萃取液體積)。加入 6000克去離子水至濃縮萃取液(4 ·· 1水/萃取液)。當水加 入時形成自色異黃酮沈澱物。沈澱漿經熱至70°C 45分 鐘。漿然後在4 °C下冷藏2 4小時,以允許異黃酮沈澱形成 及靜置。7 3 0 0克上清液自沈殿物傾倒出,及剩餘之漿經 離心以回收沈澱物。回收之沈澱物再以6 0 0克去離子水在 7 0 °C下清洗1 5分鐘。沈澱物由離心回收在眞空下在5 〇 下乾燥。 經濟部中央標準局員工消費合作社印製 乾燥配基異黃酮物質重7.3克及含49%5,7,4、三魏基 異黃酮、19%7,V-二羥基異黃酮及4%6-甲氧基_7,4\二 羥基異黃酮經獲得。 實施例5 在另1個實驗中,高5,7,V -三羥基異黃酮含量物質和 高7,4 '-二羥基異黃酮含量物質係自配基異黃酮物質由逆 相HPLC分開。2克配基異黃酮物質含55%5,7,4、三幾基 •36- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐Γ 1241347 A7 B7 五、發明説明(34 ) 異1酮、21%7,4’_二务基異黃酮和4%6-甲氧基_7,4'-二 羥基異黃酮乾重經加入1升5 〇 : 5 0重量%甲醇/水溶液。 溶液經What man 5號濾紙過濾及然後經0 45微米滤紙。 溶液然後經載入2英吋直徑2 5厘米長Η P L C管柱,填充 以 Kromsil 填充物質(Kromasil C18 16 微米,1〇〇 埃 珠)。含5 0 : 5 0重量%甲醇/水溶液之移動相然後以6 4毫 升/分之速率通過管柱。7,4'-二羥基異黃酮、6_甲氧基_ 7,4、二羥基異黃酮和5,7,4、三羥基異黃酮自管柱流出液 之出現係由U V吸收偵測。7,4 ’ -二輕基異黃酮在第1個區 分液中收集及5,7,4’-三#呈基異黃酮在第2個區分液中收 集。7,4'-二羥基異黃酮和5,7,4,-三羥基異黃酮區分液經 蒸發除去醇,導致在各個別區分液中高5,7,4,-三經基異 黃酮和高7,4 ’ -二羥基異黃酮含量物質沈澱。沈澱之高 5,7,4’ -三羥基異黃酮和高7,4’ -二羥基異黃酮含量物質由 離心回收及在眞空烘箱中乾燥。回收之高5,7,4,-三經基 異黃酮含量物質含約95 %5,7,4、三羥基異黃酮及回收之 高7,4、二#呈基異黃酮含量物質含約4.5%7,4,·二經基異 黃酮。 經濟部中央標準局員工消費合作社印製 在上述之實驗中,爲6&quot;-〇Mal_5,7,4,·三輕基異黃酮 糖甞、6〃_〇Ac-5,7,4'·三羥基異黃酮糖甞、6〃-〇Mal-7,4'-二經基異黃酮糖苷、6〃-〇Ac-7,4,·二複基異黃酮糖 甞、6&quot;-OMal-6_甲氧基-7,4、二邊基異黃酮糖苷及6_甲 氧基-7,4、二羥基異黃酮所示之所有百分比爲計算之數 値。所示之酵素濃度百分比係自各樣品中每丨〇 〇克乳漿固 -37- 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨〇&gt;&lt;297公釐1 1241347 A7 &quot; ------_ _ 五、發明説明(35 ) 形物或每1GG克乳漿(克商業酵素製備物計算。 以下爲在黃豆產物中定量異黃酮之方法之敘述。異黃酮 係自黃豆產物萃取,由混合〇75克樣品(喷霧乾燥細研粉 末)和50毫升80/20甲醇/水溶劑。混合液在室溫下在軌道 式振靈器中振盛2小時。2小時後,剩餘之未溶解物質由 過濾經Whatman 42號濾紙除去。5毫升濾液以4毫升水 和1毫升甲醇稀釋。 經濟部中央標準局員工消費合作社印製 萃取之異黃酮由HPLC(高效液相層析法)使用惠普填充 之C18 Hypersil逆相管柱分開。異黃酮經注入管柱及以 落劑梯度溶析,以8 8 %甲醇、i 〇 %水和2 %冰乙酸開始。 在0.4¾升/分之流速下,所有異黃酮-5,74,·三羥基異黃 酮糖甞、6&quot;-〇_乙醯基5,7,4'_三羥基異黃酮糖甞、6、〇_ 丙二醯基5,7,4’ -三羥基異黃酮糖甞、5,7,4,_三羥基異黃 酮、7,4’·二羥基異黃酮糖:y:、6&quot;_〇_乙醯基7,4、二羥基 異黃酮糖甞、6&quot;-0-丙二醯基7,二羥基異黃酮糖甞、 7,4、二羥基異黃酮、6_甲氧基-7,4、二羥基異黃酮糖 苷、6〃-0_丙二醯基6-甲氧基-7,4、二羥基異黃酮糖苷和 6 -甲氧基-7,4f·二經基異黃酮·清楚地解析。尖峰由uv吸 收在260亳微米下偵測。尖峰之鑑定由HPLC-質譜儀進行。 定量使用純標準物(5,7,4、三羥基異黃酮糖甞、 5,7,4f-三羥基異黃酮、7,4,_二羥基異黃酮糖菩和7,4'-二#至基異黃酮)達成,購Indofine化學公司, Sommervill e,紐澤西州。反應因子(積分面積/濃度)經 爲各以上化合物計算及用以定量未知樣品。爲無純標準物 -38 - 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨〇&gt;&lt;297公釐) 1241347 A7 ~~----- B7 五、發明説明(36 ) 可得之共耗形式,反應因子經假^爲母分子者,但修正分 6_甲氧基_7,4、二經基異黃酮糖嘗之反應因子 假疋馬5’7,4’·三幾基異黃_糖#者,並修正分子量差異。 此方法提供各個別異黃_之量。爲方便,總57,4,-三 羥基異黃酮、總7,4,_二羥基異黃酮可計算,及代表此些 化口物之聚集重f ’若所有共軏形式經轉換成其個別未共 軛形式。此些總量亦可直接由使用酸分解以轉換未共軛形 式之方法測定。 則面僅爲本發明之較佳具體實施例。不同變化和改變可 以製成’而不偏離其精神和更廣之要素,如在隨附之申請 專利範圍中所説明,其與包括相當學説之專利法律原理一 致地詮譯。 (請先閲讀背面之注意事項再填寫本頁)1T J-- 1241347 A7 --------- B7 V. Description of the invention (32) &gt; Compare 罘 1 and 2 samples of the milk protein material, and clearly concentrate the rich protein formula before separating the milk protein material. The milk aggregation of the isoflavones resulted in increased capture of aglycone isoflavones in milk protein shellfish materials. Example 4 In another experiment, the aglycone isoflavone substance was recovered, and the aglycone isoflavone serum protein substance and the self-extracting solution Shendian aglycone isoflavone substance were extracted from an aqueous alcohol extract. 821 grams of aglycone isoflavone serum protein material contains 86% dry weight protein, 4.7 grams of 5,7,4'_trihydroxy isoflavones, 22 grams of 7,4, dihydroxy isoflavones. Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. And 0.36 g of 6-methoxy_7,4 and dihydroxy isoflavones are converted from isogone and isoflavone glycosides into aglucone isoflavones and isoflavones are recovered from the slurry. Provided with milk protein material. Aglycone isoflavone serum protein The rabbit product was extracted with 6360 g of 80:20 wt% ethanol / water solution (77: j solution / aglycone isoflavone serum protein material) at 60% for 4 5 minutes. After extraction, the generated table was cooled to 25 C and filtered on Whatman No. 4 filter and paper under empty space. The wet cake weighed 1584 grams and contained 798 grams of solids, 0.8 grams of 5,7,4'-trihydroxy isoflavones, 0.4 grams of 7,4, dihydroxy isoflavones, and 0.02 grams of 6-methoxy. -7,4. Dioxo isoflavones were recovered, and together with 3397 g of clarified extract, it contained 23 g of solids, 3.9 g of 5,7,4 \ trilateral isoflavones, 1.8 g of 7,4, _ di Hydroxy isoflavones and 0.34 g of 6-methoxy-7,4, dihydroxy isoflavones. The filter cake was extracted with 2000 g of 80:20 wt% ethanol / water solution (23: 1 solution / original isoflavone serum protein material) for the second time at 25 ° C for 5 minutes. After the second extraction, the resulting pulp was then applied to Whatman No. 4 Filter Paper-35- This paper is sized to Chinese National Standard (CNS) A4 (210X297 mm) '&quot; 1241347 A7 B7 V. Description of Invention (33) filter. The wet cake weighed 1542 grams and contained 794 grams of solids, 0.3 grams of 5,7,4'-trisyl isoflavones, 0.1 grams of 7,4'-dioxane isoflavones, and 0.011 grams of 6-methoxyl. -7,4, dihydroxy isoflavones were recovered together with the second extraction solution, weighing 2042 g, containing 4.0 g of solids, 0.5 g of 5,7,4'_trihydroxy isoflavone, 0.3 g of 7,4, 2 Hydroxyl isoflavones and 0.011 g of 6-methoxy-7,4, diquinone isoflavone. The extracts were combined and contained in the first 94% of the 5,7,4, -trihydroxy isoflavones and 9 5% of the 7,4'-dihydroxy isoflavones in the isoflavone I homogenate protein material. The extract was then concentrated by evaporation in a Buchi evaporator under vacuum at 70 C to 1528 grams (20% of the original combined extract volume). Add 6000 grams of deionized water to the concentrated extract (4 ·· 1 water / extract). When water is added, a self-colored isoflavone precipitate is formed. The precipitation slurry was heated to 70 ° C for 45 minutes. The slurry is then refrigerated at 4 ° C for 24 hours to allow the isoflavones to form and stand. 7 300 grams of supernatant was decanted from Shen Dianwu, and the remaining slurry was centrifuged to recover the precipitate. The recovered precipitate was washed with 600 g of deionized water at 70 ° C for 15 minutes. The precipitate was recovered by centrifugation and dried under vacuum at 50 ° C. Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, the dry aglycone isoflavone substance weighs 7.3 grams and contains 49% 5,7,4, triweilyl isoflavones, 19% 7, V-dihydroxy isoflavones, and 4% 6- Methoxy-7,4 \ dihydroxy isoflavone was obtained. Example 5 In another experiment, a substance having a high content of 5,7, V-trihydroxy isoflavone and a substance having a high content of 7,4'-dihydroxy isoflavone were self-ligand isoflavone materials separated by reverse-phase HPLC. 2 grams of aglycone isoflavone substance contains 55% 5,7,4, trichizyl • 36- This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm Γ 1241347 A7 B7 V. Description of the invention (34) 1 ketone, 21% 7,4'-dihydroxyisoflavones, and 4% 6-methoxy-7,4'-dihydroxy isoflavones were added in dry weight by adding 1 liter of 50:50 wt% methanol / water solution. The solution was filtered through Whatman No. 5 filter paper and then through 0 45 micron filter paper. The solution was then loaded into a 2-inch diameter 25 cm long PLC column and filled with Kromsil filling material (Kromasil C18 16 micron, 100 Angstrom beads). ). Mobile phase containing 50:50 wt% methanol / water solution then passed through the column at a rate of 64 ml / min. 7,4'-dihydroxy isoflavone, 6_methoxy_7, 4, 2 The appearance of hydroxy isoflavones, 5,7,4, and trihydroxy isoflavones from the column effluent was detected by UV absorption. 7,4'-di- light isoflavones were collected in the first differentiation solution and 5,7 , 4'-Tri # presenting isoflavones were collected in the second separation solution. The 7,4'-dihydroxy isoflavone and 5,7,4, -trihydroxy isoflavone separation solution were evaporated to remove alcohol, resulting in the Individual differentiation solution Precipitation of high 5,7,4, -trisyl isoflavones and high 7,4'-dihydroxy isoflavones. Precipitation of high 5,7,4'-trihydroxy isoflavones and high 7,4 '-di The hydroxy isoflavone content material is recovered by centrifugation and dried in an air oven. The recovered high content of 5,7,4, -trisyl isoflavones contains about 95% 5,7,4, trihydroxy isoflavones and recovered high content. 7,4 、 二 # The basic isoflavone content substance contains about 4.5% 7,4,2,2ndyl isoflavones. Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs in the above experiment, it is 6 &quot; -〇Mal_5, 7,4, · trisyl isoflavone glycocalyx, 6〃_〇Ac-5,7,4 '· trihydroxy isoflavone glycoside, 6〇-〇Mal-7,4'-diazonyl isoflavone glycoside , 6〃-〇Ac-7,4, · bis-isoflavone glycoside, 6 &quot; -OMal-6_methoxy-7,4, diside isoflavone glycoside and 6_methoxy-7, 4. All the percentages shown in dihydroxy isoflavones are calculated. The percentages of enzyme concentration shown are from every sample in the sample. -37- This paper size applies to China National Standard (CNS) A4 specifications. (2 丨 〇 &gt; &lt; 297 mm 1 1241347 A7 &quot; ------_ _ V. Description of the invention (35) Shaped matter or per 1 GG grams of milk slurry (grams of commercial enzyme preparation). The following is a description of the method for quantifying isoflavones in soy products. Isoflavones are extracted from soy products and mixed with 75 G of sample (spray-dried finely ground powder) and 50 ml of 80/20 methanol / water solvent. The mixture was allowed to incubate in an orbital vibrator at room temperature for 2 hours. After 2 hours, the remaining undissolved material was removed by filtration through Whatman No. 42 filter paper. 5 ml of the filtrate was diluted with 4 ml of water and 1 ml of methanol. Printed by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs The extracted isoflavones were separated by HPLC (High Performance Liquid Chromatography) using HP packed C18 Hypersil reverse phase columns. The isoflavones were injected into a column and eluted with a gradient of gradient, starting with 88% methanol, 100% water, and 2% glacial acetic acid. At a flow rate of 0.4¾ liters / minute, all isoflavones-5,74, · trihydroxy isoflavone glycosides, 6 &quot; -〇_ethylenyl 5,7,4'_trihydroxy isoflavone glycosides, 6, 〇_ Malonyl 5,7,4'-trihydroxy isoflavone saccharin, 5,7,4, _trihydroxy isoflavone, 7,4 '· dihydroxy isoflavone sugar: y :, 6 &quot; _〇 _Ethyl 7,4, dihydroxy isoflavone glycocalyx, 6 &quot; -0-propanedifluorinyl 7, dihydroxy isoflavone glycoside, 7, 4, dihydroxy isoflavone, 6_methoxy-7, 4. Dihydroxy isoflavone glycosides, 6〃-0_propanedifluorenyl 6-methoxy-7,4, dihydroxy isoflavone glycosides and 6-methoxy-7,4f · dionyl isoflavones · clear Ground resolution. Spikes were detected by UV absorption at 260 μm. Identification of spikes was performed by HPLC-mass spectrometer. Quantitative use of pure standards (5,7,4, trihydroxy isoflavones, 5,7,4f-trihydroxy isoflavones, 7,4, _dihydroxy isoflavones, and 7,4'-di # to (Isoflavone), Indofine Chemical Company, Sommervill e, New Jersey. The response factor (integrated area / concentration) was calculated for each of the above compounds and used to quantify the unknown sample. No pure standard -38-This paper size applies the Chinese National Standard (CNS) A4 specification (2 丨 〇 &lt; 297 mm) 1241347 A7 ~~ ----- B7 V. Description of the invention (36) Yes The obtained co-consumption form, the reaction factor is false as the parent molecule, but the correction factor is 6_methoxy_7,4, the reaction factor of the dimer isoflavone sugar is tasted 5 * 7,4 ' A few bases of isoflavone_saccharide #, and correct the molecular weight difference. This method provides the amount of each individual yellow. For convenience, total 57,4, -trihydroxy isoflavones and total 7,4, _dihydroxy isoflavones can be calculated and represent the aggregate weight f 'of these compounds if all conjugated forms are converted to their individual Conjugate form. These totals can also be determined directly by a method using acid decomposition to convert the unconjugated form. This is only a preferred embodiment of the present invention. Different changes and modifications can be made without deviating from its spirit and broader elements, as explained in the scope of the accompanying patent application, which is interpreted in accordance with the principles of patent law including considerable doctrine. (Please read the notes on the back before filling this page)

Jn . -訂_Jn .-Order_

經濟部中央標準局員工消費合作社印製 -39- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs -39- This paper size applies to the Chinese National Standard (CNS) A4 (210X297 mm)

£1^%, (^以上各欄由本局填註) A4 C4 1241347 ¥明 中文說明書替換頁(93年10月)説明書 專利£ 1 ^%, (The fields above ^ are filled by this bureau) A4 C4 1241347 ¥ Ming Chinese manual replacement page (October 1993) manual Patent

中 喜I黎flllf懸II盡|成異黃酮之植物性蛋白 ^JJ^esstdttprdducinuwageucdne- i〇9SAAV.0NE ENRICHED vegetable protein whey SSi?T^yEGETABLE PROTEIN whey and materials -ERQDIICED THFPF卩ROM” ___ 發明 新型石稱 英 姓 國 文 名 籍 1.傑洛米西恩 克艾羅塞 O. 芭拉艾希瑞安 4.瑪莉安克Ϊ瑞荔Zhongxi I Li flllf Suspension II | JJ ^ esstdttprdducinuwageucdne- i〇9SAAV.0NE ENRICHED vegetable protein whey SSi? T ^ yEGETABLE PROTEIN whey and materials -ERQDIICED THFPF 卩 ROM "___ Invented a new type of stone British surnames and national names 1. Jeremy Sienke Airoser O. Barra Asherien 4. Maria Anchor

發明 創作&gt; 住、居所 ?名稱于 國 籍 均美國 1·吴國密蘇里州聖路易市凱斯廣場5937號 吴國密蘇里州聖路易市艾德魯巷5523號 ,吴國密蘇里州聖路易市波辛大道7039號 •吴國伊利諾州柯林斯威市伯尼史迪爾路16 8號 美商蛋白質科技國際公司 美國 裝Invention &gt; Residence, residence? Name and nationality are all in the U.S. 1. Wu Kwong, Missouri, 5937 Case Square, St. Louis, Wu Kwong Missouri, Edrew Lane, 5523, St. Louis, Posing No. 7039 Avenue • Wu Guo Collinsville, Illinois 16 8 Burnie Still Road, American Protein Technology International Corporation, USA

線 申請人 美國密蘇里州聖路易_盤廣 場 賴瑞·傑.郝瑞特Line Applicant St. Louis, Missouri_Pan Guangchang Larry Rui J.Horret

i i :少 !:.:ί 1241347 卜 專利i!请案〃i i: less!:.: ί 1241347 bu patent i! please file 〃

明^TT 1 〇 〇 %井黃_共軛物成異黃酮糖甞。典型地,至少9 5 %之 轉化率。此些高轉化率在大量商業操作中使用是特別吸引 人的。 」在=2個轉化步驟或操作中,在第1個步驟中產生之異黃 酮::以及留在乳漿中之異黃酮糖甞由酵素反應轉換成配 f /、只酮。轉化自富含異黃酮糖苷之乳漿產生富含配基異 黃酮之植物性蛋白質。 第2個轉化步驟經發現依在乳衆中存在之酵素濃度及其 ^而疋。疋成轉化所需之酵素為能裂解在異黃酮部分和 -二酮糖甘《葡萄糖分子間之糖棼鍵之酵素。在較佳之具 2施例中,酵素為能裂解丨,4糖錢之醣酶酵素。轉化 Ί酉同糖#成配基異黃_需之酵素濃度依多種因子而 =包括在乳”存在之酵素種類、酵素濃度分佈、酵素 異黃酮«濃度及在轉化期間乳裝之_和溫度。 :人素可天然存在於植物性蛋白質乳漿,自微生物生長存 ::L漿或可以補充物加至乳漿。天然存在或自微生物生 醅:水中而存在(酵素在此稱為“殘留,,酵素及加至乳漿 之酵素在此稱為“補充,,酵素。 所入夠Γ f素存在於讀中以轉化至少大部分及較佳地實 貝王邵兴黃酮糖菩成配某昱土 .基一界酮。通常,若在乳漿中殘留 邮七々 補无酵素應加至乳漿中。如上 所5己,多種因子決定是否酵音 #丄、… 蹲素以通㊄凑度存在以進行轉化。 右加入補充酵素時,補充_ h 、往 无酵素應加入,使存在之酵素總 痕度在乾重基準下為約〇 1 /〇 土約1 0 %乳漿固形物之重 •14-It was found that TT 100% Jinghuang_ conjugate formed isoflavone glycocalyx. Typically, a conversion of at least 95%. These high conversion rates are particularly attractive for use in a large number of commercial operations. "In the two conversion steps or operations, the isoflavones produced in the first step :: and the isoflavone glycosides left in the milk are converted by enzyme reactions into f /, ketones. Transformation from isoflavone glycoside-rich milks produces aglycone isoflavone-rich plant proteins. The second transformation step was found to be dependent on the concentration of enzymes present in the milk mass and its concentration. The enzymes required for the conversion are enzymes that can cleave the isoflavone moiety and the diketoglycan and glucose bonds between glucose molecules. In a preferred embodiment, the enzyme is a carbohydrase enzyme capable of cleaving 4,4-gold money. The enzyme concentration required for the transformation of the same sugar # 成 基基 黄黄 _ depends on a variety of factors = including the types of enzymes present in milk, the distribution of enzyme concentration, the concentration of enzyme isoflavones, and the milk temperature and temperature during the conversion. : Human can exist naturally in plant-based protein milk, which is grown from microorganisms :: L pulp or can be added to the milk. Naturally occurring or derived from microorganisms: Water exists (enzymes are referred to as "residues, Enzymes and enzymes added to the milk are referred to herein as "supplements, enzymes. Enriched Γ f exists in the reading to transform at least most and preferably the flavonoid sugar of Wang Shaoxing. Soil-based ketone. Generally, if there is residual enzyme in the milk, you should add it to the milk. As mentioned above, a variety of factors determine whether the yeast sound # 丄, ... Exist to carry out the transformation. When adding supplementary enzymes, supplement _ h, to the non-enzyme should be added, so that the total trace of the existing enzymes is about 0 1/0 soil about 10% of the weight of milk solids on a dry weight basis. • 14-

Claims (1)

^1^5^77號專利申請案 A8. 争文申請專利範圍替換本(94年7月) C8! 丨_ 丨丨 _丨丨 ———^ D8 穴、申清專利範圍 1. 一種自含異黃酮共軛物之植物性蛋白質乳衆製造富含配 基異黃酮之植物性蛋白質乳漿之方法,包括: a) 在溫度為2。0至121它之間和pH值為6至13 7之間 f理該植物性]蛋白質乳漿一段足以轉換至少8〇%之異 黃酮共軛物成異黃酮糖甞之時間;及 ’ b) 將酵素與該異黃酮糖芬在該植物性蛋白質乳漿中 在溫度為5 〇C至7 5 t之間和p Η值為3至9之間下接觸一段 足以轉換至少80%之異黃酮料至配基異黃酉同之時間 2. 根據中請專利範圍第i項之方法,#中轉換異黃網i輛 物成異黃酮糖甞之時段係在約4小時至約6小時間。” 3. 根據中請專利第β之方法,纟中轉換異黃綱共輛 物成異黃酮糖甞之時段係在約〇 . 5小時至約ι小時間。 4. 根據中請專利範圍第之方法,其中以該異黃嗣糖替 在該植物性蛋白質乳漿中接觸酵素包括添加有效量之補 充酵素至植物性蛋白質乳漿。 5_根據申請專利範圍第4項之方法,纟中補充酵素包括能 裂解1,4 -糖:y:鍵之醣酶酵素。 6. 根據申請專利範圍第5項之方法,其中補充酵素係選自 -群包括二糖#酶酵素、β_糖麵酵素、卜半乳糖_ 酵素、葡萄糖澱粉酶酵素、果膠酶酵素及其組人物 7. 根據申請專利範圍第1項之方法,其中該植 =蛋白質 乳漿包括黃豆乳漿。 8·根據申請專利範圍第1項之方法’進—步包括自核舍本 配基異黃酮之植物性蛋白質«回收含蛋白質和 本紙張尺度適用中國S家標準(CNS) Α4規格(210X297公釐 8 8 8 8 A BCD 1241347 六、申請專利範圍 黃酮之配基異黃酮乳漿蛋白質物質。 9·根據申請專利範圍第8項之方法,其中該配基異黃酮乳 漿蛋白溢物質係由至少超過濾、熱凝結和去水之一回收。 10. 根據申請專利範圍第8項之方法,其中該配基異黃酮乳 水蛋白貝物為係由冷卻該植物性蛋白質乳漿和自該冷卻 乳漿分開該配基異黃酮乳漿蛋白質物質回收。 11. 根據申請專利範圍第8項之方法,其中該配基異黃酮乳 漿蛋白質物質係自濃縮植物性蛋白質物質回收。 12·根據申凊專利範圍第§項之方法,進一步包括: a) 以水性醇萃取劑萃取該配基異黃酮乳漿蛋白質物 質,產生富含配基異黃酮之萃取液;及 b) 以吸附物質接觸該萃取液一段足以自該萃取液分 開咼5,7,4 '-三獲基異黃酮含量物質之時間。 13.根據申請專利範圍第1 2項之方法,其中該水性醇萃取劑 包括在約3 0 %醇至約9 0 %醇間。 14·根據申請專利範圍第1 2項之方法,其中該水性醇萃取劑 具約在該配基異黃酮乳漿蛋白質物質中該蛋白質等電點 之pH值。 15·根據申請專利範圍第1 4項之方法,其中該水性醇萃取劑 具在約3至約6間之ρ Η值。 16·根據申請專利範圍第1 2項之方法,其中該配基異黃酮乳 漿蛋白質物質係以該萃取劑萃取,其中萃取劑對乳漿蛋 白質物質之重量比值不超過約n : i。 17.根據申請專利範圍第1 2項之方法,其中該配基異黃酮乳 -2- 本紙張尺度適用中國國家標準(CNS) A4規格(210 &lt; 297公擎) 8 8 8 8 A B c D 1241347 六、申請專利範圍 漿蛋白質物質係以2部分之該水性醇萃取劑萃取,其中 該等部分之該萃取劑對該乳漿蛋白質物質之合併重量比 值不超過約1 1 : 1之總重量比值。 18·根據申請專利範圍第1 2項之方法,其中該吸附物質為粒 狀物。 19·根據申請專利範圍第1 2項之方法,其中以吸附物質接觸 該萃取液進一步包括在該萃取液中以該吸附物質可釋放 地結合5,7,4 '-三經基異黃酮。 20·根據申請專利範圍第1 2項之方法,其中該萃取液經該吸 附物質以溶析液溶析,自該萃取液分開高5,7,4、三經基 異黃S同含量物質。 21. 根據申請專利範圍第1 2項之方法,其中該高5,7,4、三 羥基異黃酮含量物質含至少40% 5,7,4、三羥基異黃酮。 22. 根據申請專利範圍第2 1項之方法,其中該高5,7,4 三 羥基異黃酮含量物質含至少9〇%5,7,4、三羥基異黃酮。 23·根據申請專利範圍第8項之方法,進一步包括: a) 以水性醇萃取劑萃取該配基異黃酮乳漿蛋白質物 質,產生富含配基異黃酮之萃取液;及 b) 以吸附物質接觸該萃取液一段足以自該萃取液分 開高5,7,4、三羥基異黃酮含量物質之時間。 24·根據申請專利範圍第2 3項之方法,其中該水性醇萃取劑 包括在約3 0 %醇至約9 0 %醇間。 25·根據申請專利範圍第2 3項之方法,其中該水性醇萃取劑 具約在該配基異黃酮乳漿蛋白質物質中該蛋白質等電點 -3 - 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐) 1241347 A8 B8 C8 D8 六、申請專利範圍 之pH值。 26·根據申請專利範圍第2 5項之方 、&lt;万/去,其中該水性醇萃取劑 具在約3至約6間之p Η值。 戶 玎根據申請專利範圍第23項之方法,其中該配基異普嗣乳 聚蛋白質物質係以該萃取劑萃取,其中萃取劑對乳衆蛋 白質物質之重量比值不超過約丨丨:j。 28·根據申請專利範圍第2 3項之方法,纟中該配基異黃酮乳 桌蛋白*物質係以2邵分該水性醇萃取劑萃取,其中該 等部分之該萃取劑對該乳漿蛋白質物質之合併重量比值 不超過約1 1 : 1之總重量比值。 29·根據申請專利範圍第2 3項之方法,其中該吸附物質為粒 狀物。 30.根據申請專利範圍第2 3項之方法,其中該吸附物質接觸 該萃取液進一步包括在該萃取液中以該吸附物質可释放 地結合7,V -二羥基異黃酮。 31 ·根據申請專利範圍第2 3項之方法,其中該萃取液經該吸 附物質以溶析液溶析,自該萃取液分開高7,4、二羥基異 黃酮含量物質。 32.根據申清專利範圍弟2 3項之方法,其中該南7,4 '-二經 基異黃酮含量物質含至少4 0 % 7,4 '-二經基異黃酮。 33·根據申請專利範圍第8項之方法,進一步包栝·· a) 以水性醇萃取劑萃取該配基異黃酮乳漿蛋白質物 質’產生富含配基異黃嗣之萃取液;及 b) 以吸附物質接觸該萃取液一段足以自該萃取液分 -4- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1241347 A8 B8 C8 D8 、申請專利範圍 開含6-甲氧基-7,4'-二羥基異黃酮含量物質之時間。 34·根據申請專利範圍第8項之方法,進一步包括: a) 以水性醇萃取劑萃取該配基異黃酮乳漿蛋白質物 貝’產生富含配基異黃酮之萃取液; b) 濃縮該富含配基異黃酮之萃取液至在約丨5 %至約 3 〇 %間之其原來體積;及 c) 由加水至該萃取液沈澱配基異黃酮物質。 35·根據申請專利範圍第3 4項之方法,其中該水性醇萃取劑 含在約3 0 %至約9 0 %間之醇。 36·根據申請專利範圍第34項之方法,其中該配基異黃酮乳 漿蛋白質物質係以該萃取劑萃取,其中萃取劑對乳漿蛋 白質物質之重量比值不超過約1 1 : i。 •根據申凊專利範圍第3 4項之方法,其中該配基異黃酮乳 裝蛋白質物質係以2部分之該水性醇萃取劑萃取,其中 孩等部分之該萃取劑對該乳漿蛋白質物質之合併重量比 值不超過1 1 : 1之總重量比值。 38’根據申請專利範圍第3 4項之方法,其中該水性醇萃取劑 具約在該配基異黃酮乳漿蛋白質物質中該蛋白質等電點 之pH值。 39·根據申請專利範圍第38之方法,其中該水性醇萃取劑具 在約3至約6間之ρ η值。 4〇·根據申請專利範圍第3 4項之方法,其中水經加入該萃取 液’其中水對萃取液之重量比值係在約6 ·· 1至約8 ·· 1間。 41·根據申請專利範圍第3 4項之方法,進一步包括以水清洗 -5- 本紙張尺度相巾_家辟(cns) ^视格(別〉〈撕公貪) A8 B8 1241347 申請專利範圍 沈澱之配基異黃酮物質,其中水對該配基異黃酮物質之 重量比值係在約〇 · 8 : 1至約2 ·· 1間。 42·根據中請專利範圍第3 4項之方法,進一步包括冷卻萃取 液和水,以最大化該配基異黃酉同物質之沈殿。 43.根據申請專利範圍第34項之方法,進一步包括: a) 以水性醇溶液中溶劑溶合該配基異黃酮物質;及 b) 以吸附物質接觸含該溶劑溶合之配基異黃酮物質 之忒水性醇洛液一段足以自該水性醇溶液分開高5,7,4,_ 二#至基異黃酮含量物質之時間。 44·根據申請專利範圍第3 4項之方法,進一步包括: a) 以水性醇溶液中溶劑溶合該配基異黃酮物質;及 b) 以吸附物質接觸含該溶劑溶合之配基異黃酮物質 又蔹水性醇溶液一段足以自該水性醇溶液分開高7,4、二 %基異黃酮含量物質之時間。 45· 一種根據申請專利範圍第工項之方法製造之富含配基異 黃酮之植物性蛋白質乳漿。 牴根據申請專利範圍第45項之富含配基異黃酮之植物性蛋 白乳漿,其包括根據申請專利範圍第8項之方法製造之 配基異黃酮乳漿蛋白質物質。 仪根據申請專利範圍第以項之富含配基異黃酮之植物性蛋 白乳漿,其包括根據申請專利範圍第12項之方法製造之 向5,7,4 -二每基異黃酿]含量物質。 48·根據申請專利範圍第45項之富含配基異黃酮之植物性蛋 白乳漿,其包括根據申請專利範圍第23項之方法製造: -6- A B c D 1241347 六、申請專利範圍 高7,4 '-二羥基異黃酮含量物質。 49. 根據申請專利範圍第4 5項之富含配基異黃酮之植物性蛋 白乳漿,其包括根據申請專利範圍第4 3項之方法製造之 高5,7,4'-三羥基異黃酮含量物質。 50. 根據申請專利範圍第4 5項之富含配基異黃酮之植物性蛋 白乳漿,其包括根據申請專利範圍第44項之方法製造之 高7,4 '-二羥基異黃酮含量物質。 51. 根據申請專利範圍第4 5項之富含配基異黃酮之植物性蛋 白乳漿,其包括根據申請專利範圍第3 4項之方法製造之 配基異黃酮物質。 52. —種由申請專利範圍第1項之方法製得之配基異黃酮物 質,包括黃豆物質、至少1 0 % 5,7,4 '-三羥基異黃酮和 至少5 % 7,4 '-二羥基異黃酮。 53. 根據申請專利範圍第5 2項之配基異黃酮物質,其包括由 申請專利範圍第12項之方法製得之高5,7,4'-三羥基異 黃酮含量物質,包括黃豆物質和至少4 0 % 5,7,4 '-三羥 基異黃酮。 54. 根據申請專利範圍第5 3項之配基異黃酮物質,其中高 5,7,4 '-三羥基異黃酮含量物質含至少9 0 % 5,7,4 三羥 基異黃酮。 55. 根據申請專利範圍第5 2項之配基異黃酮物質,其包括由 申請專利範圍第3 2項之方法製得之高7,4 '-二羥基異黃 酮含量物質,包括黃豆物質和至少4 0 % 7,4 '-二羥基異 黃酮。 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)^ 1 ^ 5 ^ 77 patent application A8. Replacement text for patent application scope (July 1994) C8! 丨 _ 丨 丨 _ 丨 丨 ———— ^ D8 hole, application scope for patent application 1. A self-contained Method for making isoflavone conjugate-based plant protein milks A method for producing plant-based protein milks rich in aglycone isoflavones, including: a) at a temperature between 2.0 and 121 and a pH of 6 to 13 7 The reason is that the plant-based] protein milk is for a time sufficient to convert at least 80% of the isoflavone conjugates into isoflavone glycocalyxes; and 'b) the enzyme and the isoflavone saccharin are added to the plant-based protein milk The pulp is contacted for a period of time sufficient to convert at least 80% of the isoflavone material to the ligand isoflavone at a temperature between 50 ° C and 7 5 t and a pΗ value between 3 and 9. 2. According to the scope of the patent claimed In the method of item i, the time period for converting the isoflavones to isoflavone saccharin in # is from about 4 hours to about 6 hours. 3. According to the method of patent application β, the time period in which Zhongzhong converts isoflavones into isoflavone sugar is about 0.5 hours to about 1 hour. 4. According to the patent application Method, wherein contacting an enzyme with the isoflavone sugar in the plant protein milk slurry includes adding an effective amount of supplementary enzyme to the plant protein milk slurry. 5_ According to the method of claim 4 in the scope of the patent application, the enzyme is supplemented in the lotus root. Including glycosidase enzymes that can cleave 1,4-sugar: y: bonds. 6. The method according to item 5 of the scope of the patent application, wherein the supplementary enzyme is selected from the group consisting of disaccharides # enzyme enzymes, β_sugar enzymes, Galactose _ enzymes, glucoamylase enzymes, pectinase enzymes and their group members 7. The method according to item 1 of the scope of patent application, wherein the plant = protein milk slurry includes soybean milk. 8. According to the scope of the patent application Method 1 of 'Procedure-further includes self-nucleating phytoproteins of the isoflavone flavonoids «recycling protein and paper size applicable to China Standards (CNS) A4 specifications (210X297 mm 8 8 8 8 A BCD 1241347 Application for patent The flavonoid isoflavone serum protein material. 9. The method according to item 8 of the patent application scope, wherein the aglycone isoflavone milk protein overflow material is recovered by at least one of ultrafiltration, thermal coagulation, and dewatering. 10. The method according to item 8 of the scope of patent application, wherein the aglycone isoflavone lactoprotein shellfish is recovered by cooling the plant protein milk slurry and separating the aglycone isoflavone milk protein material from the cooled milk slurry. 11. The method according to item 8 of the scope of patent application, wherein the aglycone isoflavone milk protein material is recovered from the concentrated plant protein material. 12. The method according to item § of the scope of patent application, further comprising: a) Extracting the aglycone isoflavone proteinaceous material with an aqueous alcohol extractant to produce an aglycone isoflavone-rich extract; and b) contacting the extract with an adsorbent for a period of time sufficient to separate from the extract 咼 5, 7, 4 The time of the isoflavone-containing substance. 13. The method according to item 12 of the patent application scope, wherein the aqueous alcohol extractant is included between about 30% alcohol and about 90% alcohol. 14 · root The method according to item 12 of the patent application, wherein the aqueous alcohol extractant has a pH value of the isoelectric point of the protein in the protein substance of the isoflavone emulsion. 15. The method according to item 14 of the patent application Wherein the aqueous alcohol extractant has a ρ ρ value between about 3 and about 6. 16. The method according to item 12 of the scope of patent application, wherein the aglycone isoflavone slurry protein substance is extracted with the extractant, The weight ratio of the extractant to the protein content of the syrup does not exceed about n: i. 17. The method according to item 12 of the scope of the patent application, wherein the ligand isoflavone milk-2- This paper size applies to Chinese national standards (CNS ) A4 specification (210 &lt; 297 engine) 8 8 8 8 AB c D 1241347 VI. Patent application scope Pulp protein material is extracted with 2 parts of the aqueous alcohol extractant, where the extractant of these parts is used for the milk The combined weight ratio of the pulp protein material does not exceed a total weight ratio of about 1 1: 1. 18. The method according to item 12 of the scope of the patent application, wherein the adsorbent is a particulate matter. 19. The method according to item 12 of the scope of patent application, wherein contacting the extraction solution with an adsorbent further comprises releasably binding 5,7,4'-trisyl isoflavone in the extract with the adsorbent. 20. The method according to item 12 of the scope of application for a patent, wherein the extract is eluted by the eluent through the adsorbent, and the extract is separated from the extract with a high content of 5, 7, 4, and three warp-based iso yellow S. 21. The method according to item 12 of the scope of patent application, wherein the substance having a high content of 5,7,4, and trihydroxy isoflavones contains at least 40% of 5,7,4, and trihydroxy isoflavones. 22. The method according to item 21 of the scope of patent application, wherein the substance having a high content of 5,7,4 trihydroxy isoflavones contains at least 90% of 5,7,4, trihydroxy isoflavones. 23. The method according to item 8 of the scope of patent application, further comprising: a) extracting the aglycone isoflavone proteinaceous material with an aqueous alcohol extractant to produce an aglucone isoflavone-rich extract; and b) adsorbing the substance The extract is contacted for a time sufficient to separate from the extract a substance having a high 5,7,4, trihydroxy isoflavone content. 24. The method according to item 23 of the scope of patent application, wherein the aqueous alcohol extractant is included between about 30% alcohol and about 90% alcohol. 25. The method according to item 23 of the scope of patent application, wherein the water-based alcohol extractant has an isoelectric point of the protein in the protein substance of the isoflavone emulsion -3-This paper applies Chinese National Standard (CNS) A4 specification (210X297 mm) 1241347 A8 B8 C8 D8 6. pH value in the scope of patent application. 26. According to the method of item 25 of the scope of application for patents, &lt; 10,000 / to, wherein the aqueous alcohol extractant has a p Η value between about 3 and about 6. The household according to the method of the scope of application for the patent No. 23, wherein the ligand isopuertomilk polyprotein substance is extracted with the extractant, and the weight ratio of the extractant to the milk protein substances does not exceed about 丨: j. 28. According to the method of item 23 of the scope of the applied patent, the aglycone isoflavone lactate protein * in the mash is extracted with 2 parts of the aqueous alcohol extractant, and the extractant of these parts of the extract protein has The combined weight ratio of the substances does not exceed a total weight ratio of about 1 1: 1. 29. The method according to item 23 of the scope of patent application, wherein the adsorbent is a particulate matter. 30. The method according to item 23 of the scope of patent application, wherein contacting the adsorbent with the extract further comprises releasably binding 7, V-dihydroxy isoflavone with the adsorbent in the extract. 31. The method according to item 23 of the scope of application for a patent, wherein the extract is eluted with an eluent through the adsorption substance, and a substance having a high content of 7,4, dihydroxy isoflavone is separated from the extract. 32. The method according to claim 23 of the scope of patent application, wherein the content of the 7,4'-dianyl isoflavone in the south contains at least 40% of 7,4'-dianyl isoflavone. 33 · According to the method in the scope of the patent application No. 8, further comprising: a) extracting the aglycone isoflavone proteinaceous material with an aqueous alcohol extractant to produce an aglycone isoflavone-rich extract; and b) The adsorbed substance is in contact with the extract for a period of time. This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X 297 mm). 1241347 A8 B8 C8 D8. The scope of patent application includes 6-methoxy group. -7,4'-Dihydroxy isoflavone content substance time. 34. The method according to item 8 of the scope of patent application, further comprising: a) extracting the aglycone isoflavone slurry protein material with an aqueous alcohol extractant to produce an aglycone isoflavone-rich extract; b) concentrating the rich Aqueous isoflavone-containing extract to its original volume between about 5% and about 30%; and c) adding water to the extract to precipitate aglycone isoflavone material. 35. The method according to item 34 of the scope of the patent application, wherein the aqueous alcohol extractant contains an alcohol between about 30% and about 90%. 36. The method according to item 34 of the patent application, wherein the aglycone isoflavone milk protein substance is extracted with the extractant, and the weight ratio of the extractant to the milk protein substance does not exceed about 1 1: i. • The method according to item 34 of the patent scope of the patent, wherein the aglycone isoflavone milk protein material is extracted with 2 parts of the aqueous alcohol extractant, and the child part of the extractant is The combined weight ratio does not exceed a total weight ratio of 1 1: 1. 38 'The method according to item 34 of the scope of the patent application, wherein the aqueous alcohol extractant has a pH value about the isoelectric point of the protein in the protein substance of the isoflavone slurry. 39. The method according to claim 38, wherein the aqueous alcohol extractant has a ρ η value between about 3 and about 6. 40. The method according to item 34 of the scope of the patent application, wherein water is added to the extraction liquid ', and the weight ratio of water to the extraction liquid is between about 6 ·· 1 to about 8 ·· 1. 41. The method according to item 34 of the scope of patent application, further comprising washing with water-5-paper-scale paper towels _ Jia Pi (cns) ^ Grid (Others) <Tear Public Corruption] A8 B8 1241347 A ligand isoflavone substance, wherein the weight ratio of water to the ligand isoflavone substance is between about 0.8: 1 to about 2.1. 42. The method according to item 34 of the Chinese Patent Application, further comprising cooling the extraction liquid and water to maximize the Shen Dian of the same compound of isoxanthin. 43. The method according to item 34 of the scope of patent application, further comprising: a) dissolving the ligand isoflavone substance in a solvent in an aqueous alcohol solution; and b) contacting the adsorbent substance containing the ligand isoflavone substance with the solvent Zhishui Aqueous Alcohol Solution is a period of time sufficient to separate from the aqueous alcohol solution a high 5,7,4, _ di # to a base isoflavone content substance. 44. The method according to item 34 of the scope of patent application, further comprising: a) solvent dissolving the ligand isoflavone substance in an aqueous alcohol solution; and b) contacting the adsorbent substance with the ligand isoflavone substance dissolved in the solvent The substance is then held in the aqueous alcohol solution for a time sufficient to separate from the aqueous alcohol solution a substance having a high 7,4,2% isoflavone content. 45. An aglycone isoflavone-rich plant protein milk made according to the method in the scope of patent application.配 The aglycone isoflavone-rich plant protein milk according to the scope of the patent application No. 45, which comprises the aglycone isoflavone proteinaceous material manufactured according to the method of the patent scope No. 8. According to the scope of the scope of the patent application, the plant protein milk slurry rich in aglycone isoflavones includes the content of 5,7,4 -2 per base isoflavone produced according to the method of the scope of the scope of patent application]. substance. 48. The isoflavone-rich plant protein milk slurry according to item 45 of the scope of patent application, which includes manufacturing according to the method of item 23 of the scope of patent application: -6- AB c D 1241347 6. The scope of patent application is high 7 , 4'-Dihydroxy isoflavone content substance. 49. The aglycone isoflavone-rich plant protein milk according to item 45 of the patent application scope, which comprises a high 5,7,4'-trihydroxy isoflavone manufactured according to the method of item 43 of the patent application scope. Content substance. 50. The aglycone isoflavone-rich plant protein milk according to item 45 of the scope of the patent application, which includes a substance having a high content of 7,4'-dihydroxy isoflavone manufactured according to the method of the scope of the patent application 44. 51. The aglycone isoflavone-rich plant protein milk according to item 45 of the scope of the patent application, which comprises an isoflavone substance manufactured according to the method of the scope of the patent application scope 34. 52. An aglycone isoflavone substance prepared by the method of claim 1 in the scope of patent application, including soy substance, at least 10% 5,7,4'-trihydroxy isoflavone and at least 5% 7,4'- Dihydroxy isoflavones. 53. Ligand isoflavone substances according to item 52 of the scope of patent application, which include substances with a high content of 5,7,4'-trihydroxy isoflavone prepared by the method of item 12 of the scope of patent application, including soy substance and At least 40% 5,7,4'-trihydroxy isoflavones. 54. The aglycone isoflavone substance according to item 53 of the scope of the patent application, wherein the substance with a high 5,7,4'-trihydroxy isoflavone content contains at least 90% 5,7,4 trihydroxy isoflavone. 55. The aglycone isoflavone substance according to item 52 of the scope of patent application, which includes a substance having a high content of 7,4′-dihydroxy isoflavone prepared by the method of item 32 of the scope of patent application, including soy substance and at least 40% 7,4'-dihydroxy isoflavones. This paper size applies to China National Standard (CNS) A4 (210 X 297 mm)
TW86115277A 1996-04-03 1997-10-17 A process for producing an aglucone isoflavone enriched vegetable protein whey from a vegetable protein whey and materials produced therefrom TWI241347B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/627,301 US5851792A (en) 1996-04-03 1996-04-03 Aglucone isoflavone enriched vegetable protein whey whey protein material aglucone isoflavone material high genistein content material and high daidzein content material and process for producing the same from a vegetable protein whey

Publications (1)

Publication Number Publication Date
TWI241347B true TWI241347B (en) 2005-10-11

Family

ID=37013927

Family Applications (1)

Application Number Title Priority Date Filing Date
TW86115277A TWI241347B (en) 1996-04-03 1997-10-17 A process for producing an aglucone isoflavone enriched vegetable protein whey from a vegetable protein whey and materials produced therefrom

Country Status (1)

Country Link
TW (1) TWI241347B (en)

Similar Documents

Publication Publication Date Title
RU2152434C1 (en) Method of preparing extract enriched with isoflavone aglycons from plant material (variants), method of extraction of material with high content of genistein or daidzein from material enriched with isoflavone aglycons
KR100412117B1 (en) Methods for recovering isoflavones from soybean molasses
TW491851B (en) An aglucone isoflavone enriched vegetable protein concentrate and process for producing
TW493002B (en) Two-step conversion of vegetable protein isoflavone conjugates to aglucones
TW491852B (en) An aglucone isoflavone enriched vegetable protein extract and isolate and process for producing
JP3787844B2 (en) Aglycon isoflavone-enriched plant protein whey, whey protein, and method for producing the same
JP3534844B2 (en) Protein isolate containing a large amount of isoflavone compound and method for producing the same
US5851792A (en) Aglucone isoflavone enriched vegetable protein whey whey protein material aglucone isoflavone material high genistein content material and high daidzein content material and process for producing the same from a vegetable protein whey
CA2391247C (en) Water-soluble bean-based extracts
TWI241347B (en) A process for producing an aglucone isoflavone enriched vegetable protein whey from a vegetable protein whey and materials produced therefrom
KR100379642B1 (en) A process of manufacturing highly purified isoflavone aglycones by fermentation
KR100413025B1 (en) Aglucon isoflavone-enriched vegetable protein whey, whey protein material, aglucon isoflavone material, high zenistein content, high diad zein content and vegetable protein whey
JP3609273B2 (en) Plant protein extracts and isolates rich in aglycone isoflavones and methods for their production
AU735303B2 (en) Aglucone isoflavone enriched vegetable protein whey, whey protein material, aglucone isoflavone material, high genistein content material, and high daidzein content material and process for producing the same from a vegetable protein whey
RU2309603C2 (en) Method for production of plant whey material enriched with aglucon isoflavone (variants), method for production of material with high content of genisteine and daidzeine
JPH11155592A (en) Aglycone isoflavone-enriched vegetable proteinaceous whey, whey proteinaceous substance, aglycone isoflavone substance, highly genisteine-containing substance and highly daidzein-containing substance and production thereof from vegetable proteinaceous whey
AU731389B2 (en) Preparation of isoflavones from legumes
TW491895B (en) An aglucone isoflavone enriched vegetable protein whey, whey protein and process for producing
MXPA98000653A (en) Serum of vegetable protein enriched with aglucone isoflavone, serum protein material, aglucone isoflavone material, genistein high content and material with high content of daidzein, and procedure to produce them from a vege protein serum
MXPA98003598A (en) An extract and isolated vegetable protein enriched with aglucone isoflavone, and procedure to produce
MXPA97006806A (en) Extract of vegetable protein and protein material enriched with aglucon isoflavone, and high content genistein and daidzein materials and procedure to produce myself

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees